| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | endopeptidase activity | KLK6 ADAM20 USP11 ADAM18 ACR ADAM9 PSMA6 ADAM10 USP20 CAPN8 TMPRSS3 KEL USP1 CAPN2 PRSS55 TMPRSS12 ADAM29 ADAM32 ADAM12 KLK4 ADAM33 USP33 | 4.98e-09 | 430 | 228 | 22 | GO:0004175 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | RELN IMPG1 FBN1 FBN2 FGB SRPX COL4A6 FRAS1 LAMA2 LAMA4 HMCN1 PCOLCE2 MUC2 AGRN | 3.58e-08 | 188 | 228 | 14 | GO:0005201 |
| GeneOntologyMolecularFunction | peptidase activity | RELN KLK6 ADAM20 USP11 ADAM18 ACR ADAM9 PSMA6 ADAM10 USP20 CAPN8 TMPRSS3 USP32 KEL USP1 CAPN2 PRSS55 TMPRSS12 ADAM29 ADAM32 ADAM12 KLK4 ADAM33 TNFAIP3 USP33 | 1.37e-07 | 654 | 228 | 25 | GO:0008233 |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 9.83e-06 | 120 | 228 | 9 | GO:0004222 | |
| GeneOntologyMolecularFunction | calcium ion binding | CLSTN3 SRI STAB1 CAPN8 FAT1 FBN1 FBN2 PLA2G12B JAG1 USP32 PLCD1 EFCAB6 ASAH2 PCDHGA1 FAT3 CAPN2 PPEF2 CLSTN1 PPEF1 HMCN1 NCAN AGRN | 5.11e-05 | 749 | 228 | 22 | GO:0005509 |
| GeneOntologyMolecularFunction | X11-like protein binding | 3.86e-04 | 3 | 228 | 2 | GO:0042988 | |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase activity | 4.56e-04 | 86 | 228 | 6 | GO:0004197 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 5.03e-04 | 200 | 228 | 9 | GO:0008237 | |
| GeneOntologyBiologicalProcess | binding of sperm to zona pellucida | 1.08e-07 | 52 | 231 | 8 | GO:0007339 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | CFH RELN SPEM3 ADAM9 ITGB4 AHDC1 CFHR4 STAB1 MEOX2 FBN2 NRXN3 NF1 NFATC3 BSG JAG1 NECTIN2 EMC10 C3 PLCD1 ACTL9 HERC1 FOXC2 GPR4 SEMA3C SHROOM3 MBOAT7 PRAMEF19 DUSP1 FAT3 CAPN2 TMPRSS12 SIRT6 AQP1 ADAM12 KLK4 ALX1 CSF1R CCN2 TNFAIP3 | 5.05e-07 | 1483 | 231 | 39 | GO:0048646 |
| GeneOntologyBiologicalProcess | sperm-egg recognition | 6.39e-07 | 65 | 231 | 8 | GO:0035036 | |
| GeneOntologyBiologicalProcess | single fertilization | ADAM20 ADAM18 ACR GLIPR1L1 ACTL9 ALDOA ZAN PRSS55 TMPRSS12 ADAM32 LHFPL2 CFAP57 | 4.42e-06 | 209 | 231 | 12 | GO:0007338 |
| GeneOntologyBiologicalProcess | fertilization | ADAM20 ADAM18 ACR NECTIN2 GLIPR1L1 ACTL9 ALDOA ZAN PRSS55 TMPRSS12 ADAM32 LHFPL2 CFAP57 | 9.04e-06 | 263 | 231 | 13 | GO:0009566 |
| GeneOntologyBiologicalProcess | cell-cell recognition | 9.09e-06 | 92 | 231 | 8 | GO:0009988 | |
| GeneOntologyBiologicalProcess | activation of membrane attack complex | 2.71e-05 | 6 | 231 | 3 | GO:0001905 | |
| GeneOntologyBiologicalProcess | regulation of synapse organization | RELN CLSTN3 MYCBP2 MDGA2 LRRTM3 ADAM10 C1QL1 NF1 NRXN2 L1CAM CLSTN1 ACTR2 TIAM1 NCAN AGRN | 3.34e-05 | 387 | 231 | 15 | GO:0050807 |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | RELN CLSTN3 MYCBP2 MDGA2 LRRTM3 ADAM10 C1QL1 NF1 NRXN2 L1CAM CLSTN1 ACTR2 TIAM1 NCAN AGRN | 4.21e-05 | 395 | 231 | 15 | GO:0050803 |
| GeneOntologyBiologicalProcess | cell recognition | ADAM18 ACR NCAM2 GLIPR1L1 ALDOA ZAN L1CAM PRSS55 TMPRSS12 ADAM32 | 8.27e-05 | 198 | 231 | 10 | GO:0008037 |
| GeneOntologyBiologicalProcess | synapse organization | RELN CLSTN3 MYCBP2 MDGA2 LRRTM3 ADAM10 C1QL1 FZD9 NRXN3 NF1 NRXN2 CHRDL1 C3 ACTL9 L1CAM CLSTN1 ACTR2 TIAM1 NCAN AGRN | 9.53e-05 | 685 | 231 | 20 | GO:0050808 |
| GeneOntologyBiologicalProcess | camera-type eye morphogenesis | 1.37e-04 | 171 | 231 | 9 | GO:0048593 | |
| GeneOntologyBiologicalProcess | retinal pigment epithelium development | 1.57e-04 | 10 | 231 | 3 | GO:0003406 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | RELN IMPG1 ADAM10 ITGB4 FBN1 FBN2 FGB SRPX COL4A6 LAMB4 SEMA3C FRAS1 L1CAM LAMA2 LAMA4 TGFB1I1 HMCN1 NCAN PCOLCE2 CCN2 MUC2 AGRN | 1.17e-07 | 530 | 231 | 22 | GO:0062023 |
| GeneOntologyCellularComponent | extracellular matrix | RELN IMPG1 LRRTM3 ADAM10 ITGB4 FBN1 FBN2 FGB SRPX COL4A6 LAMB4 SEMA3C FRAS1 ZAN L1CAM LAMA2 LAMA4 TGFB1I1 HMCN1 NCAN PCOLCE2 CCN2 MUC2 AGRN | 3.09e-07 | 656 | 231 | 24 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | RELN IMPG1 LRRTM3 ADAM10 ITGB4 FBN1 FBN2 FGB SRPX COL4A6 LAMB4 SEMA3C FRAS1 ZAN L1CAM LAMA2 LAMA4 TGFB1I1 HMCN1 NCAN PCOLCE2 CCN2 MUC2 AGRN | 3.26e-07 | 658 | 231 | 24 | GO:0030312 |
| GeneOntologyCellularComponent | basement membrane | 8.69e-06 | 122 | 231 | 9 | GO:0005604 | |
| GeneOntologyCellularComponent | cell-substrate junction | SCARF2 ADAM9 ADAM10 ITGB4 FAT1 BSG NECTIN2 FHL1 CAPN2 L1CAM ACTR2 TGFB1I1 IGF2R HMCN1 RPL5 USP33 | 3.64e-05 | 443 | 231 | 16 | GO:0030055 |
| GeneOntologyCellularComponent | secretory granule | KLK6 ACR ACTR10 GARS1 SRI ADAM10 NIT2 TMEM179B BSG FGB GLIPR1L1 C3 ACTL9 ALDOA DMXL2 ATG7 PRAMEF19 PRSS55 KCNAB2 TMPRSS12 LCN2 AQP1 ACTR2 KLK4 IGF2R LHFPL2 | 5.96e-05 | 1014 | 231 | 26 | GO:0030141 |
| GeneOntologyCellularComponent | GABA-ergic synapse | 9.03e-05 | 164 | 231 | 9 | GO:0098982 | |
| GeneOntologyCellularComponent | focal adhesion | SCARF2 ADAM9 ADAM10 ITGB4 FAT1 BSG NECTIN2 FHL1 CAPN2 L1CAM ACTR2 TGFB1I1 IGF2R RPL5 USP33 | 9.67e-05 | 431 | 231 | 15 | GO:0005925 |
| GeneOntologyCellularComponent | secretory vesicle | KLK6 ACR ACTR10 GARS1 SRI ADAM10 KCNK9 NIT2 TMEM179B BSG FGB GLIPR1L1 C3 ACTL9 ALDOA DMXL2 ATG7 PRAMEF19 PRSS55 KCNAB2 TMPRSS12 LCN2 AQP1 ACTR2 SLC32A1 KLK4 IGF2R TRIM9 LHFPL2 | 1.21e-04 | 1246 | 231 | 29 | GO:0099503 |
| GeneOntologyCellularComponent | sarcolemma | 2.74e-04 | 190 | 231 | 9 | GO:0042383 | |
| GeneOntologyCellularComponent | sperm head | 3.18e-04 | 30 | 231 | 4 | GO:0061827 | |
| GeneOntologyCellularComponent | synaptic cleft | 4.62e-04 | 33 | 231 | 4 | GO:0043083 | |
| GeneOntologyCellularComponent | cell cortex | MYO10 ITGB4 MKLN1 FGB SHROOM3 CAPN2 SHROOM2 ACTR2 CLIP4 HMCN1 PDE4DIP CCN2 | 9.13e-04 | 371 | 231 | 12 | GO:0005938 |
| GeneOntologyCellularComponent | axon | CFH RELN MYCBP2 ACTR10 GARS1 SRI NCAM2 ADAM10 CFHR4 C1QL1 NF1 ACTL9 IL31RA ATG7 L1CAM KCNAB2 TXNRD2 AQP1 SLC32A1 TIAM1 AGRN | 9.33e-04 | 891 | 231 | 21 | GO:0030424 |
| GeneOntologyCellularComponent | somatodendritic compartment | CFH RELN CLSTN3 MYO10 SRI ADAM10 CFHR4 NF1 TMPRSS3 GNB1 GOT2 NCOA2 FAT3 CAPN2 L1CAM LAMA2 TXNRD2 CLSTN1 SHROOM2 AQP1 RGS12 SLC32A1 CSF1R TIAM1 TRIM9 USP33 | 1.13e-03 | 1228 | 231 | 26 | GO:0036477 |
| GeneOntologyCellularComponent | Sec61 translocon complex | 1.19e-03 | 5 | 231 | 2 | GO:0005784 | |
| GeneOntologyCellularComponent | anchoring junction | CADM3 SCARF2 ADAM9 ADAM10 ITGB4 FAT1 BSG JAG1 NECTIN2 FHL1 SHROOM3 CAPN2 L1CAM SHROOM2 ACTR2 TGFB1I1 IGF2R HMCN1 TIAM1 MARVELD2 RPL5 USP33 | 1.26e-03 | 976 | 231 | 22 | GO:0070161 |
| GeneOntologyCellularComponent | photoreceptor inner segment | 1.73e-03 | 78 | 231 | 5 | GO:0001917 | |
| GeneOntologyCellularComponent | translocon complex | 1.77e-03 | 6 | 231 | 2 | GO:0071256 | |
| MousePheno | decreased circulating complement protein level | 1.04e-05 | 4 | 194 | 3 | MP:0020216 | |
| MousePheno | abnormal retina rod bipolar cell morphology | 1.34e-05 | 23 | 194 | 5 | MP:0006074 | |
| MousePheno | abnormal craniofacial morphology | MYO10 PFAS MDGA2 FOXN3 ADAM10 ITGB4 AHDC1 PTH1R SLC39A13 MEOX2 FAT1 CFAP54 FBN1 FBN2 NF1 NFATC3 JAG1 MYBPHL GNB1 USP1 GOT2 FOXC2 FRAS1 SHROOM3 MBOAT7 SGSH L1CAM LAMA2 SIRT6 SLC32A1 ZDHHC20 KLK4 IGF2R ALX1 CSF1R CCN2 MARVELD2 RPL5 | 2.52e-05 | 1372 | 194 | 38 | MP:0000428 |
| MousePheno | craniofacial phenotype | MYO10 PFAS MDGA2 FOXN3 ADAM10 ITGB4 AHDC1 PTH1R SLC39A13 MEOX2 FAT1 CFAP54 FBN1 FBN2 NF1 NFATC3 JAG1 MYBPHL GNB1 USP1 GOT2 FOXC2 FRAS1 SHROOM3 MBOAT7 SGSH L1CAM LAMA2 SIRT6 SLC32A1 ZDHHC20 KLK4 IGF2R ALX1 CSF1R CCN2 MARVELD2 RPL5 | 2.52e-05 | 1372 | 194 | 38 | MP:0005382 |
| MousePheno | abnormal circulating complement protein level | 5.10e-05 | 6 | 194 | 3 | MP:0010215 | |
| MousePheno | absent vestibular hair cells | 1.40e-04 | 8 | 194 | 3 | MP:0004325 | |
| MousePheno | abnormal retina bipolar cell morphology | 1.49e-04 | 37 | 194 | 5 | MP:0006073 | |
| MousePheno | abnormal mesangial cell morphology | 1.69e-04 | 38 | 194 | 5 | MP:0005327 | |
| MousePheno | white pupil | 1.92e-04 | 2 | 194 | 2 | MP:0006242 | |
| MousePheno | artery occlusion | 1.92e-04 | 2 | 194 | 2 | MP:0006134 | |
| MousePheno | abnormal hepatic portal vein thrombosis | 1.92e-04 | 2 | 194 | 2 | MP:0031159 | |
| MousePheno | decreased serum complement activity | 1.92e-04 | 2 | 194 | 2 | MP:0012553 | |
| MousePheno | decreased complement C5 level | 1.92e-04 | 2 | 194 | 2 | MP:0012609 | |
| MousePheno | abnormal complement C5 level | 1.92e-04 | 2 | 194 | 2 | MP:0012608 | |
| MousePheno | abnormal complement protein level | 2.08e-04 | 9 | 194 | 3 | MP:0011566 | |
| Domain | EGF-like_dom | RELN IMPG1 SCARF2 ADAM20 ADAM18 ADAM9 STAB1 FAT1 FBN1 FBN2 NRXN3 NRXN2 JAG1 ATRN FRAS1 ZAN FAT3 LAMA2 LAMA4 ADAM29 ADAM32 ADAM12 HMCN1 NCAN ADAM33 AGRN | 5.66e-17 | 249 | 229 | 26 | IPR000742 |
| Domain | EGF_1 | RELN SCARF2 ADAM20 ADAM18 ADAM9 ITGB4 STAB1 FAT1 FBN1 FBN2 NRXN3 NRXN2 JAG1 ATRN LAMB4 ZAN FAT3 LAMA2 LAMA4 ADAM29 ADAM32 ADAM12 HMCN1 NCAN ADAM33 AGRN | 1.02e-16 | 255 | 229 | 26 | PS00022 |
| Domain | EGF-like_CS | RELN SCARF2 ADAM20 ADAM18 ADAM9 ITGB4 STAB1 FAT1 FBN1 FBN2 NRXN3 NRXN2 JAG1 ATRN LAMB4 ZAN FAT3 LAMA2 LAMA4 ADAM29 ADAM32 ADAM12 HMCN1 NCAN ADAM33 AGRN | 1.81e-16 | 261 | 229 | 26 | IPR013032 |
| Domain | EGF_2 | RELN SCARF2 ADAM20 ADAM18 ADAM9 ITGB4 STAB1 FAT1 FBN1 FBN2 NRXN3 NRXN2 JAG1 ATRN LAMB4 ZAN FAT3 LAMA2 ADAM29 ADAM32 ADAM12 HMCN1 NCAN ADAM33 AGRN | 2.55e-15 | 265 | 229 | 25 | PS01186 |
| Domain | EGF_3 | RELN SCARF2 ADAM20 ADAM18 ADAM9 STAB1 FAT1 FBN1 FBN2 NRXN3 NRXN2 JAG1 ATRN ZAN FAT3 ADAM29 ADAM32 ADAM12 HMCN1 NCAN ADAM33 AGRN | 1.52e-13 | 235 | 229 | 22 | PS50026 |
| Domain | EGF | RELN SCARF2 ADAM9 STAB1 FAT1 FBN1 FBN2 NRXN3 NRXN2 JAG1 ATRN FRAS1 ZAN FAT3 LAMA2 LAMA4 ADAM32 HMCN1 NCAN ADAM33 AGRN | 1.38e-12 | 235 | 229 | 21 | SM00181 |
| Domain | - | 5.02e-11 | 20 | 229 | 8 | 4.10.70.10 | |
| Domain | Disintegrin | 8.02e-11 | 21 | 229 | 8 | PF00200 | |
| Domain | DISIN | 8.02e-11 | 21 | 229 | 8 | SM00050 | |
| Domain | EGF_extracell | RELN SCARF2 ADAM18 ADAM9 ITGB4 STAB1 JAG1 ATRN ADAM32 ADAM12 ADAM33 | 1.50e-10 | 60 | 229 | 11 | IPR013111 |
| Domain | EGF_2 | RELN SCARF2 ADAM18 ADAM9 ITGB4 STAB1 JAG1 ATRN ADAM32 ADAM12 ADAM33 | 1.50e-10 | 60 | 229 | 11 | PF07974 |
| Domain | Disintegrin_CS | 3.96e-10 | 16 | 229 | 7 | IPR018358 | |
| Domain | ADAM_CR | 1.08e-09 | 18 | 229 | 7 | PF08516 | |
| Domain | Pep_M12B_propep | 2.00e-08 | 39 | 229 | 8 | PF01562 | |
| Domain | Peptidase_M12B_N | 2.00e-08 | 39 | 229 | 8 | IPR002870 | |
| Domain | DISINTEGRIN_1 | 2.48e-08 | 40 | 229 | 8 | PS00427 | |
| Domain | Reprolysin | 2.48e-08 | 40 | 229 | 8 | PF01421 | |
| Domain | ADAM_MEPRO | 2.48e-08 | 40 | 229 | 8 | PS50215 | |
| Domain | DISINTEGRIN_2 | 2.48e-08 | 40 | 229 | 8 | PS50214 | |
| Domain | Peptidase_M12B | 2.48e-08 | 40 | 229 | 8 | IPR001590 | |
| Domain | ADAM_Cys-rich | 2.74e-08 | 27 | 229 | 7 | IPR006586 | |
| Domain | ACR | 2.74e-08 | 27 | 229 | 7 | SM00608 | |
| Domain | Disintegrin_dom | 3.05e-08 | 41 | 229 | 8 | IPR001762 | |
| Domain | EGF_Lam | 1.91e-07 | 35 | 229 | 7 | SM00180 | |
| Domain | Laminin_EGF | 1.91e-07 | 35 | 229 | 7 | PF00053 | |
| Domain | DUSP | 3.24e-07 | 6 | 229 | 4 | PF06337 | |
| Domain | DUSP | 3.24e-07 | 6 | 229 | 4 | SM00695 | |
| Domain | LAM_G_DOMAIN | 3.47e-07 | 38 | 229 | 7 | PS50025 | |
| Domain | Laminin_EGF | 3.47e-07 | 38 | 229 | 7 | IPR002049 | |
| Domain | ConA-like_dom | CLSTN3 MDGA2 ITGB4 FAT1 NRXN3 NRXN2 HERC1 ZAN FAT3 LAMA2 LAMA4 CLSTN1 TRIM9 AGRN | 5.56e-07 | 219 | 229 | 14 | IPR013320 |
| Domain | DUSP | 7.49e-07 | 7 | 229 | 4 | PS51283 | |
| Domain | - | 7.49e-07 | 7 | 229 | 4 | 3.30.2230.10 | |
| Domain | Pept_C19_DUSP | 7.49e-07 | 7 | 229 | 4 | IPR006615 | |
| Domain | LamG | 9.90e-07 | 44 | 229 | 7 | SM00282 | |
| Domain | EGF_LAM_2 | 1.48e-06 | 30 | 229 | 6 | PS50027 | |
| Domain | EGF_LAM_1 | 1.48e-06 | 30 | 229 | 6 | PS01248 | |
| Domain | - | 2.52e-06 | 95 | 229 | 9 | 2.60.120.200 | |
| Domain | EGF | 3.51e-06 | 126 | 229 | 10 | PF00008 | |
| Domain | Growth_fac_rcpt_ | SCARF2 STAB1 FAT1 FBN1 FBN2 JAG1 ELAPOR1 ATRN FRAS1 HMCN1 CCN2 | 3.63e-06 | 156 | 229 | 11 | IPR009030 |
| Domain | VWC | 6.33e-06 | 38 | 229 | 6 | SM00214 | |
| Domain | Laminin_G | 6.72e-06 | 58 | 229 | 7 | IPR001791 | |
| Domain | - | 6.73e-06 | 81 | 229 | 8 | 3.40.390.10 | |
| Domain | MetalloPept_cat_dom | 6.73e-06 | 81 | 229 | 8 | IPR024079 | |
| Domain | Laminin_G_2 | 8.62e-06 | 40 | 229 | 6 | PF02210 | |
| Domain | VWF_dom | 1.15e-05 | 42 | 229 | 6 | IPR001007 | |
| Domain | EGF_CA | 1.97e-05 | 122 | 229 | 9 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 2.24e-05 | 124 | 229 | 9 | IPR001881 | |
| Domain | ASX_HYDROXYL | 3.19e-05 | 100 | 229 | 8 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 4.86e-05 | 106 | 229 | 8 | IPR000152 | |
| Domain | VWFC_1 | 7.33e-05 | 36 | 229 | 5 | PS01208 | |
| Domain | VWC_out | 7.38e-05 | 19 | 229 | 4 | SM00215 | |
| Domain | VWFC_2 | 9.57e-05 | 38 | 229 | 5 | PS50184 | |
| Domain | 2pore_dom_K_chnl_TASK | 1.45e-04 | 9 | 229 | 3 | IPR003092 | |
| Domain | SecY_su_dom | 1.50e-04 | 2 | 229 | 2 | IPR023201 | |
| Domain | SECY_1 | 1.50e-04 | 2 | 229 | 2 | PS00755 | |
| Domain | SECY_2 | 1.50e-04 | 2 | 229 | 2 | PS00756 | |
| Domain | - | 1.50e-04 | 2 | 229 | 2 | 1.10.3370.10 | |
| Domain | Translocon_Sec61/SecY_plug_dom | 1.50e-04 | 2 | 229 | 2 | IPR019561 | |
| Domain | SecY_CS | 1.50e-04 | 2 | 229 | 2 | IPR030659 | |
| Domain | Plug_translocon | 1.50e-04 | 2 | 229 | 2 | PF10559 | |
| Domain | SecY | 1.50e-04 | 2 | 229 | 2 | PF00344 | |
| Domain | Ser/Thr-Pase_EF-hand_contain | 1.50e-04 | 2 | 229 | 2 | IPR012008 | |
| Domain | SecY/SEC61-alpha | 1.50e-04 | 2 | 229 | 2 | IPR002208 | |
| Domain | EGF_Ca-bd_CS | 1.92e-04 | 97 | 229 | 7 | IPR018097 | |
| Domain | ZINC_PROTEASE | 2.04e-04 | 98 | 229 | 7 | PS00142 | |
| Domain | EGF_CA | 2.17e-04 | 99 | 229 | 7 | PS01187 | |
| Domain | Calsyntenin | 4.45e-04 | 3 | 229 | 2 | IPR026914 | |
| Domain | ASD1 | 4.45e-04 | 3 | 229 | 2 | PF08688 | |
| Domain | ASD1_dom | 4.45e-04 | 3 | 229 | 2 | IPR014800 | |
| Domain | ASD1 | 4.45e-04 | 3 | 229 | 2 | PS51306 | |
| Domain | FBN | 4.45e-04 | 3 | 229 | 2 | IPR011398 | |
| Domain | Ig_I-set | 5.77e-04 | 190 | 229 | 9 | IPR013098 | |
| Domain | I-set | 5.77e-04 | 190 | 229 | 9 | PF07679 | |
| Domain | Neurexin-like | 5.99e-04 | 14 | 229 | 3 | IPR003585 | |
| Domain | 4.1m | 5.99e-04 | 14 | 229 | 3 | SM00294 | |
| Domain | EGF_CA | 6.61e-04 | 86 | 229 | 6 | PF07645 | |
| Domain | 2pore_dom_K_chnl | 7.42e-04 | 15 | 229 | 3 | IPR003280 | |
| Domain | EFh | 7.53e-04 | 158 | 229 | 8 | SM00054 | |
| Domain | TRYPSIN_SER | 8.40e-04 | 90 | 229 | 6 | IPR033116 | |
| Domain | Neural_cell_adh | 8.84e-04 | 4 | 229 | 2 | IPR009138 | |
| Domain | PPP5 | 8.84e-04 | 4 | 229 | 2 | PF08321 | |
| Domain | Ubiquitin_3 | 8.84e-04 | 4 | 229 | 2 | PF14836 | |
| Domain | Ub_USP-typ | 8.84e-04 | 4 | 229 | 2 | IPR028135 | |
| Domain | Shroom_fam | 8.84e-04 | 4 | 229 | 2 | IPR027685 | |
| Domain | PPP_dom | 8.84e-04 | 4 | 229 | 2 | IPR013235 | |
| Domain | ASD2_dom | 8.84e-04 | 4 | 229 | 2 | IPR014799 | |
| Domain | ASD2 | 8.84e-04 | 4 | 229 | 2 | PF08687 | |
| Domain | ASD2 | 8.84e-04 | 4 | 229 | 2 | PS51307 | |
| Domain | USP_CS | 1.29e-03 | 66 | 229 | 5 | IPR018200 | |
| Domain | - | CADM3 MYCBP2 NCAM2 MDGA2 ITGB4 IGSF10 FNDC7 NFATC3 BSG NECTIN2 MYBPHL SEMA3C IL31RA L1CAM CSF1R HMCN1 TRIM9 NCAN | 1.42e-03 | 663 | 229 | 18 | 2.60.40.10 |
| Domain | EF_Hand_1_Ca_BS | 1.45e-03 | 175 | 229 | 8 | IPR018247 | |
| Domain | Laminin_domII | 1.46e-03 | 5 | 229 | 2 | IPR010307 | |
| Domain | Guanine_nucleotide-bd_bsu | 1.46e-03 | 5 | 229 | 2 | IPR016346 | |
| Domain | Laminin_aI | 1.46e-03 | 5 | 229 | 2 | IPR009254 | |
| Domain | Laminin_I | 1.46e-03 | 5 | 229 | 2 | PF06008 | |
| Domain | Laminin_II | 1.46e-03 | 5 | 229 | 2 | PF06009 | |
| Domain | USP_1 | 1.68e-03 | 70 | 229 | 5 | PS00972 | |
| Domain | TRYPSIN_HIS | 1.69e-03 | 103 | 229 | 6 | IPR018114 | |
| Domain | UCH | 1.79e-03 | 71 | 229 | 5 | PF00443 | |
| Domain | USP_2 | 1.79e-03 | 71 | 229 | 5 | PS00973 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | PHYKPL ADAM9 ADAM10 ITGB4 CAPN8 FBN1 FBN2 BSG FGB COL4A6 CAPN2 LAMA2 LAMA4 ADAM12 NCAN PCOLCE2 AGRN | 2.33e-07 | 300 | 177 | 17 | M610 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | PHYKPL ADAM10 ITGB4 CAPN8 FBN1 FBN2 BSG FGB COL4A6 CAPN2 LAMA4 ADAM12 PCOLCE2 AGRN | 4.69e-06 | 258 | 177 | 14 | MM14572 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 6.77e-05 | 140 | 177 | 9 | M587 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 8.77e-05 | 84 | 177 | 7 | M7098 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 9.36e-05 | 114 | 177 | 8 | MM14571 | |
| Pathway | WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS | 1.22e-04 | 21 | 177 | 4 | M39343 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | CFH CLSTN3 MYCBP2 ADAM9 ADAM10 ITGB4 SLC39A13 IGSF10 MELTF FAT1 FBN1 FBN2 GANAB NF1 BSG NECTIN2 TMEM131L EMC10 SEC61A1 ATRN COL4A6 SEMA3C FRAS1 MBOAT7 SGSH L1CAM LAMA4 ALG11 SLC43A3 CLSTN1 ADAM12 IGF2R PCOLCE2 CCN2 AGRN | 3.65e-13 | 1201 | 235 | 35 | 35696571 |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | CFH ADAM9 ADAM10 CFHR4 FBN1 C3 ALDOA SEMA3C LAMA2 LAMA4 LCN2 CLSTN1 ADAM12 CCN2 AGRN | 1.82e-10 | 248 | 235 | 15 | 24006456 |
| Pubmed | CFH RELN CLSTN3 MYCBP2 USP11 ADAM9 SRI NCAM2 HUNK STAB1 FBN1 USP32 MKLN1 GNB1 FHL1 ALDOA NCOA2 ATRN DMXL2 SETMAR HECTD4 KCNAB2 CLIC6 SHROOM2 ZNF251 CLIP4 VPS9D1 TIAM1 TRIM9 PDE4DIP CCN2 USP33 | 2.28e-10 | 1285 | 235 | 32 | 35914814 | |
| Pubmed | ADAM10 FBN1 FGB COL4A6 SEMA3C FRAS1 LAMA2 LAMA4 HMCN1 PCOLCE2 MUC2 AGRN | 1.78e-09 | 167 | 235 | 12 | 22159717 | |
| Pubmed | SCARF2 ADAM9 ADAM10 FAT1 BSG NECTIN2 FHL1 CAPN2 L1CAM ACTR2 TGFB1I1 IGF2R RPL5 | 8.65e-08 | 285 | 235 | 13 | 21423176 | |
| Pubmed | Potassium channel TASK-5 forms functional heterodimers with TASK-1 and TASK-3 to break its silence. | 3.05e-07 | 3 | 235 | 3 | 39215006 | |
| Pubmed | Comparison of surface recognition and C3b binding properties of mouse and human complement factor H. | 3.05e-07 | 3 | 235 | 3 | 16023208 | |
| Pubmed | 3.05e-07 | 3 | 235 | 3 | 23747511 | ||
| Pubmed | 3.54e-07 | 175 | 235 | 10 | 28071719 | ||
| Pubmed | Sall1 balances self-renewal and differentiation of renal progenitor cells. | 3.62e-07 | 67 | 235 | 7 | 24550112 | |
| Pubmed | CFH KLK6 TMEM126B FOXN3 NDUFV1 USP20 FAT1 NF1 PLA2G12B TECPR2 CHRDL1 C3 ZNF345 EFCAB6 ATG7 SGSH LAMA4 RDH5 ALG11 LCN2 SEC61A2 MFSD2A QPRT SHCBP1 PDE4DIP RPL5 | 8.08e-07 | 1293 | 235 | 26 | 15342556 | |
| Pubmed | The development of atypical hemolytic uremic syndrome depends on complement C5. | 1.21e-06 | 4 | 235 | 3 | 21148255 | |
| Pubmed | Factor H facilitates the clearance of GBM bound iC3b by controlling C3 activation in fluid phase. | 1.21e-06 | 4 | 235 | 3 | 19411110 | |
| Pubmed | 1.21e-06 | 4 | 235 | 3 | 16324103 | ||
| Pubmed | 1.21e-06 | 4 | 235 | 3 | 24279761 | ||
| Pubmed | 1.21e-06 | 4 | 235 | 3 | 37499656 | ||
| Pubmed | Complement factor H binds malondialdehyde epitopes and protects from oxidative stress. | 1.21e-06 | 4 | 235 | 3 | 21979047 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MYCBP2 MYO10 MAML1 PFAS ITGB4 AHDC1 PRR12 PLEKHG1 FAT1 EXOSC6 PCYT2 HERC1 FRAS1 SHROOM3 L1CAM AOC2 HECTD4 INO80 TXNRD2 IGF2R ARAP3 TNFAIP3 AGRN | 2.05e-06 | 1105 | 235 | 23 | 35748872 |
| Pubmed | C3-dependent mechanism of microglial priming relevant to multiple sclerosis. | 3.02e-06 | 5 | 235 | 3 | 22219359 | |
| Pubmed | Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. | 3.02e-06 | 5 | 235 | 3 | 14993236 | |
| Pubmed | 3.02e-06 | 5 | 235 | 3 | 20042240 | ||
| Pubmed | Regulation of C3 Activation by the Alternative Complement Pathway in the Mouse Retina. | 3.02e-06 | 5 | 235 | 3 | 27564415 | |
| Pubmed | Roles for phagocytic cells and complement in controlling relapsing fever infection. | 3.02e-06 | 5 | 235 | 3 | 19458267 | |
| Pubmed | CADM3 ADAM18 MDGA2 LRRTM3 ARID5A BSG TMPRSS3 PRRT3 ELAPOR1 GLIPR1L1 EMC10 C1QTNF2 IL31RA PRSS55 ADAM32 CDCP1 ADAM12 MFSD2A SEC22C ADAM33 PCOLCE2 | 4.03e-06 | 985 | 235 | 21 | 12975309 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | CFH ADAM9 SRI MELTF GANAB NECTIN2 FGB C3 GNB1 ALDOA GOT2 ATRN SEMA3C SGSH LCN2 AQP1 ACTR2 IGF2R HMCN1 QPRT GNB4 AGRN | 4.19e-06 | 1070 | 235 | 22 | 23533145 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | CENPB MYCBP2 MYO10 USP11 PSMA6 PFAS USP20 BSG USP32 SRPX ASCC3 ALDOA USP1 SEC61A1 LAMB4 SEC61A2 PDE12 IGF2R SHCBP1 TNFAIP3 USP33 | 5.48e-06 | 1005 | 235 | 21 | 19615732 |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | CLSTN3 TMEM126B PFAS ADAM10 ITGB4 HNRNPL NFATC3 RBMS3 NECTIN2 TMPRSS3 ELMOD3 ALDOA SPOCD1 ATG7 MBOAT7 POLD1 INO80 TGFB1I1 SEC61A2 TNFAIP3 | 5.61e-06 | 925 | 235 | 20 | 28986522 |
| Pubmed | 6.00e-06 | 6 | 235 | 3 | 36658650 | ||
| Pubmed | Dimerization of complement factor H-related proteins modulates complement activation in vivo. | 6.00e-06 | 6 | 235 | 3 | 23487775 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | SCARF2 ADAM9 FAT1 NF1 BSG JAG1 NECTIN2 USP32 ELMOD3 MBOAT7 CDCP1 RGS12 C2orf72 ZDHHC20 IGF2R | 8.85e-06 | 569 | 235 | 15 | 30639242 |
| Pubmed | 9.36e-06 | 42 | 235 | 5 | 15146195 | ||
| Pubmed | MYCBP2 USP11 TMEM126B PFAS NDUFV1 HP1BP3 PLEKHG1 GANAB BSG NECTIN2 TMEM131L EMC10 ASCC3 SEC61A1 DMXL2 FRAS1 SHROOM3 MBOAT7 POLD1 SEC61A2 PDE12 IGF2R TIAM1 MARVELD2 RPL5 USP33 | 1.00e-05 | 1487 | 235 | 26 | 33957083 | |
| Pubmed | Murine systemic thrombophilia and hemolytic uremic syndrome from a factor H point mutation. | 1.04e-05 | 7 | 235 | 3 | 28057640 | |
| Pubmed | 1.04e-05 | 7 | 235 | 3 | 19861685 | ||
| Pubmed | 1.04e-05 | 7 | 235 | 3 | 15907280 | ||
| Pubmed | The mouse mahogany locus encodes a transmembrane form of human attractin. | 1.04e-05 | 7 | 235 | 3 | 10086356 | |
| Pubmed | 1.04e-05 | 7 | 235 | 3 | 15280379 | ||
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | CFH KLK6 CELF4 CHIA MYO10 USP11 SLC25A30 PTH1R USP20 HP1BP3 CFHR4 PLEKHG1 NF1 MYBPHL HERC1 DMXL2 MMS22L SETMAR PRAMEF19 DUSP1 TRMO TGFB1I1 USP33 | 1.37e-05 | 1242 | 235 | 23 | 30973865 |
| Pubmed | 1.43e-05 | 210 | 235 | 9 | 16537572 | ||
| Pubmed | 1.66e-05 | 8 | 235 | 3 | 17344430 | ||
| Pubmed | 1.66e-05 | 8 | 235 | 3 | 10527948 | ||
| Pubmed | MYO10 GARS1 AHDC1 CAPN8 FAT1 UGCG EXOSC6 CAPN2 CDCP1 CLSTN1 CCN2 | 1.82e-05 | 332 | 235 | 11 | 37433992 | |
| Pubmed | 1.90e-05 | 81 | 235 | 6 | 12838346 | ||
| Pubmed | 2.48e-05 | 9 | 235 | 3 | 12122015 | ||
| Pubmed | 2.48e-05 | 9 | 235 | 3 | 18947875 | ||
| Pubmed | 2.48e-05 | 9 | 235 | 3 | 9707552 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | CLSTN3 SCARF2 ADAM9 GCDH ADAM10 NDUFV1 GANAB BSG NECTIN2 EMC10 ASCC3 GNB1 SEC61A1 MBOAT7 SGSH CAPN2 CLSTN1 PDE12 IGF2R | 2.52e-05 | 942 | 235 | 19 | 31073040 |
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 2.70e-05 | 26 | 235 | 4 | 34189436 | |
| Pubmed | Calsyntenins function as synaptogenic adhesion molecules in concert with neurexins. | 2.71e-05 | 52 | 235 | 5 | 24613359 | |
| Pubmed | ZNF143 MYCBP2 AHDC1 FAT1 FBN2 NF1 NECTIN2 EMC10 ASCC3 NCOA2 COL4A6 SEMA3C FAT3 AOC2 LAMA2 GRB14 SIRT6 ACTR2 NCAN SHCBP1 LHFPL2 AGRN | 2.97e-05 | 1215 | 235 | 22 | 15146197 | |
| Pubmed | Circulating AIM prevents hepatocellular carcinoma through complement activation. | 3.53e-05 | 10 | 235 | 3 | 25284781 | |
| Pubmed | 3.53e-05 | 10 | 235 | 3 | 12433946 | ||
| Pubmed | Harnessing host enhancers of SARS-CoV-2 entry as novel targets for antiviral therapy. | 3.57e-05 | 55 | 235 | 5 | 38945485 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 3.91e-05 | 135 | 235 | 7 | 28675934 | |
| Pubmed | ZNF143 ADAM9 PFAS HP1BP3 PRR12 SEC61A1 SEMA3C DMXL2 FRAS1 CLSTN1 ARAP3 SHCBP1 AGRN RPL5 USP33 | 4.12e-05 | 650 | 235 | 15 | 38777146 | |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | GALE ACTR10 PSMA6 GARS1 ITGB4 AHDC1 HNRNPL EXOSC6 FGB C3 PLCD1 SEMA3C RBMS2 EIF4E1B CCN2 RPL5 | 4.36e-05 | 732 | 235 | 16 | 34732716 |
| Pubmed | 4.55e-05 | 2 | 235 | 2 | 23807092 | ||
| Pubmed | Absence of complement factor H reduces physical performance in C57BL6 mice. | 4.55e-05 | 2 | 235 | 2 | 32962822 | |
| Pubmed | New Evidence Supporting the Role of FBN1 in the Development of Adolescent Idiopathic Scoliosis. | 4.55e-05 | 2 | 235 | 2 | 30044367 | |
| Pubmed | Transgenic mice expressing variants of complement factor H develop AMD-like retinal findings. | 4.55e-05 | 2 | 235 | 2 | 20538999 | |
| Pubmed | 4.55e-05 | 2 | 235 | 2 | 15131124 | ||
| Pubmed | Inheritance, hormonal regulation and properties of polymorphic murine antigens Mud1 and Mud2. | 4.55e-05 | 2 | 235 | 2 | 4992636 | |
| Pubmed | Retinal changes precede visual dysfunction in the complement factor H knockout mouse. | 4.55e-05 | 2 | 235 | 2 | 23844226 | |
| Pubmed | 4.55e-05 | 2 | 235 | 2 | 19549636 | ||
| Pubmed | 4.55e-05 | 2 | 235 | 2 | 26374608 | ||
| Pubmed | A gene locus concerned with an antigenic serum substance in Mus musculus. | 4.55e-05 | 2 | 235 | 2 | 4955525 | |
| Pubmed | Complement factor H: spatial and temporal expression and localization in the eye. | 4.55e-05 | 2 | 235 | 2 | 16936129 | |
| Pubmed | 4.55e-05 | 2 | 235 | 2 | 20333347 | ||
| Pubmed | 4.55e-05 | 2 | 235 | 2 | 24932805 | ||
| Pubmed | 4.55e-05 | 2 | 235 | 2 | 33558624 | ||
| Pubmed | 4.55e-05 | 2 | 235 | 2 | 37940659 | ||
| Pubmed | Microfibril structure masks fibrillin-2 in postnatal tissues. | 4.55e-05 | 2 | 235 | 2 | 20404337 | |
| Pubmed | 4.55e-05 | 2 | 235 | 2 | 30705315 | ||
| Pubmed | A role for TASK-1 (KCNK3) channels in the chemosensory control of breathing. | 4.55e-05 | 2 | 235 | 2 | 18753386 | |
| Pubmed | 4.55e-05 | 2 | 235 | 2 | 33859044 | ||
| Pubmed | Fibrillln mutations in Marfan syndrome and related phenotypes. | 4.55e-05 | 2 | 235 | 2 | 8791520 | |
| Pubmed | Regulation of age-related macular degeneration-like pathology by complement factor H. | 4.55e-05 | 2 | 235 | 2 | 25991857 | |
| Pubmed | ADAM33 and ADAM12 genetic polymorphisms and their expression in Egyptian children with asthma. | 4.55e-05 | 2 | 235 | 2 | 26553447 | |
| Pubmed | ADAM9 enhances CDCP1 protein expression by suppressing miR-218 for lung tumor metastasis. | 4.55e-05 | 2 | 235 | 2 | 26553452 | |
| Pubmed | Serological survey of complement factor H in common laboratory and wild mice: a new third allotype. | 4.55e-05 | 2 | 235 | 2 | 2522412 | |
| Pubmed | Absence of complement factor H alters bone architecture and dynamics. | 4.55e-05 | 2 | 235 | 2 | 30107932 | |
| Pubmed | 4.55e-05 | 2 | 235 | 2 | 34054871 | ||
| Pubmed | Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. | 4.55e-05 | 2 | 235 | 2 | 7744963 | |
| Pubmed | 4.55e-05 | 2 | 235 | 2 | 17562771 | ||
| Pubmed | 4.55e-05 | 2 | 235 | 2 | 18824070 | ||
| Pubmed | 4.55e-05 | 2 | 235 | 2 | 26408953 | ||
| Pubmed | Arg-Gly-Asp-containing domains of fibrillins-1 and -2 distinctly regulate lung fibroblast migration. | 4.55e-05 | 2 | 235 | 2 | 18006876 | |
| Pubmed | Local complement factor H protects kidney endothelial cell structure and function. | 4.55e-05 | 2 | 235 | 2 | 34139209 | |
| Pubmed | Circulating FH Protects Kidneys From Tubular Injury During Systemic Hemolysis. | 4.55e-05 | 2 | 235 | 2 | 32849636 | |
| Pubmed | Death by color: differential cone loss in the aging mouse retina. | 4.55e-05 | 2 | 235 | 2 | 24929970 | |
| Pubmed | TASK-5, a novel member of the tandem pore K+ channel family. | 4.55e-05 | 2 | 235 | 2 | 11680614 | |
| Pubmed | 4.55e-05 | 2 | 235 | 2 | 23469078 | ||
| Pubmed | 4.55e-05 | 2 | 235 | 2 | 30139996 | ||
| Pubmed | 4.55e-05 | 2 | 235 | 2 | 27991559 | ||
| Pubmed | 4.55e-05 | 2 | 235 | 2 | 18094244 | ||
| Pubmed | 4.55e-05 | 2 | 235 | 2 | 15574507 | ||
| Pubmed | 4.55e-05 | 2 | 235 | 2 | 19454698 | ||
| Pubmed | Energetic evaluation of binding modes in the C3d and Factor H (CCP 19-20) complex. | 4.55e-05 | 2 | 235 | 2 | 25628052 | |
| Pubmed | 4.55e-05 | 2 | 235 | 2 | 17517971 | ||
| Pubmed | 4.55e-05 | 2 | 235 | 2 | 20445496 | ||
| Interaction | SERPINC1 interactions | 3.13e-06 | 56 | 228 | 7 | int:SERPINC1 | |
| Interaction | CBLN4 interactions | 1.45e-05 | 127 | 228 | 9 | int:CBLN4 | |
| Interaction | RSPH1 interactions | 1.85e-05 | 131 | 228 | 9 | int:RSPH1 | |
| Interaction | IGFL3 interactions | 2.23e-05 | 75 | 228 | 7 | int:IGFL3 | |
| Cytoband | 8p11.22 | 4.62e-05 | 14 | 235 | 3 | 8p11.22 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 7.40e-11 | 27 | 164 | 8 | 47 | |
| GeneFamily | Cadherin related | 1.42e-05 | 17 | 164 | 4 | 24 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.12e-04 | 161 | 164 | 8 | 593 | |
| GeneFamily | Laminin subunits | 1.52e-04 | 12 | 164 | 3 | 626 | |
| GeneFamily | Ubiquitin specific peptidases | 1.52e-04 | 56 | 164 | 5 | 366 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | ADAM10 ITGB4 FZD9 MELTF BSG JAG1 NECTIN2 KEL L1CAM CDCP1 IGF2R CSF1R | 2.59e-04 | 394 | 164 | 12 | 471 |
| GeneFamily | Proteases, serine | 2.66e-04 | 63 | 164 | 5 | 738 | |
| GeneFamily | Potassium two pore domain channel subfamily K | 3.08e-04 | 15 | 164 | 3 | 277 | |
| GeneFamily | Fibronectin type III domain containing | 6.49e-04 | 160 | 164 | 7 | 555 | |
| GeneFamily | EF-hand domain containing | 8.85e-04 | 219 | 164 | 8 | 863 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.77e-03 | 57 | 164 | 4 | 1179 | |
| GeneFamily | Complement system|Sushi domain containing | 4.20e-03 | 36 | 164 | 3 | 492 | |
| GeneFamily | Glycosyltransferase family 6|Blood group antigens | 4.54e-03 | 37 | 164 | 3 | 454 | |
| GeneFamily | Short chain dehydrogenase/reductase superfamily | 5.04e-03 | 76 | 164 | 4 | 743 | |
| GeneFamily | Protein phosphatase catalytic subunits|EF-hand domain containing | 5.97e-03 | 13 | 164 | 2 | 693 | |
| Coexpression | NABA_CORE_MATRISOME | RELN IMPG1 IGSF10 FNDC7 FBN1 FBN2 FGB SRPX COL4A6 LAMB4 FRAS1 LAMA2 LAMA4 HMCN1 NCAN PCOLCE2 CCN2 AGRN | 5.91e-11 | 275 | 233 | 18 | M5884 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | RELN IGSF10 FNDC7 FBN1 FBN2 FGB SRPX LAMB4 FRAS1 LAMA2 LAMA4 HMCN1 PCOLCE2 CCN2 AGRN | 2.80e-10 | 196 | 233 | 15 | M3008 |
| Coexpression | NABA_CORE_MATRISOME | RELN IMPG1 IGSF10 FNDC7 FBN1 FBN2 FGB SRPX COL4A6 FRAS1 LAMA2 LAMA4 HMCN1 NCAN PCOLCE2 CCN2 AGRN | 3.73e-10 | 270 | 233 | 17 | MM17057 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | RELN IGSF10 FNDC7 FBN1 FBN2 FGB SRPX FRAS1 LAMA2 LAMA4 HMCN1 PCOLCE2 CCN2 AGRN | 1.96e-09 | 191 | 233 | 14 | MM17059 |
| Coexpression | NABA_MATRISOME | RELN IMPG1 ADAM20 ADAM18 ADAM9 ADAM10 C1QL1 IGSF10 FNDC7 FBN1 FBN2 FGB CHRDL1 C1QTNF2 SRPX COL4A6 LAMB4 SEMA3C FRAS1 LAMA2 LAMA4 ADAM29 ADAM32 ADAM12 HMCN1 NCAN ADAM33 PCOLCE2 CCN2 MUC2 AGRN | 2.88e-09 | 1026 | 233 | 31 | M5889 |
| Coexpression | NABA_MATRISOME | RELN IMPG1 ADAM20 ADAM18 ADAM9 ADAM10 C1QL1 IGSF10 FNDC7 FBN1 FBN2 FGB CHRDL1 C1QTNF2 SRPX COL4A6 SEMA3C FRAS1 LAMA2 LAMA4 ADAM29 ADAM32 ADAM12 HMCN1 NCAN ADAM33 PCOLCE2 CCN2 MUC2 AGRN | 7.48e-09 | 1008 | 233 | 30 | MM17056 |
| Coexpression | WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP | 7.39e-07 | 20 | 233 | 5 | M1792 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN | 1.13e-06 | 152 | 233 | 10 | M16842 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.38e-06 | 40 | 233 | 6 | M5887 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | CFH MYO10 NCAM2 PTH1R FAT1 FBN1 NRXN3 SLCO1C1 NRXN2 RBMS3 JAG1 NECTIN2 CHRDL1 SRPX HSD11B2 FHL1 HMGCLL1 FOXC2 FAT3 LAMA4 MFSD2A CCN2 | 1.57e-06 | 767 | 233 | 22 | M39209 |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER | 1.60e-06 | 41 | 233 | 6 | M47988 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN | 1.81e-06 | 160 | 233 | 10 | MM974 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 3.97e-06 | 137 | 233 | 9 | M40313 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 5.03e-06 | 141 | 233 | 9 | M10381 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER_TUMOR_CELL_DERIVED | 5.31e-06 | 29 | 233 | 5 | M47987 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 6.68e-06 | 146 | 233 | 9 | MM973 | |
| Coexpression | GOZGIT_ESR1_TARGETS_DN | SLC25A30 NCAM2 ZNF229 SLC39A13 FAT1 JAG1 NECTIN2 PRRT3 UGCG ELAPOR1 EMC10 HMGCLL1 SEMA3C FRAS1 SHROOM3 RBMS2 AOX1 LCN2 SHROOM2 HMCN1 TNFAIP3 | 8.15e-06 | 786 | 233 | 21 | M10961 |
| Coexpression | MURARO_PANCREAS_DUCTAL_CELL | CFH MYO10 ADAM9 ADAM10 ITGB4 ADCY5 STAB1 MELTF FAT1 JAG1 NECTIN2 UGCG C3 HSD11B2 ALDOA GOT2 SHROOM3 DUSP1 CAPN2 SLC43A3 LCN2 AQP1 ACTR2 IGF2R CSF1R LHFPL2 CCN2 TNFAIP3 | 1.03e-05 | 1276 | 233 | 28 | M39173 |
| Coexpression | CAIRO_LIVER_DEVELOPMENT_DN | 1.06e-05 | 239 | 233 | 11 | MM1274 | |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_UP | 1.31e-05 | 200 | 233 | 10 | M5003 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 1.39e-05 | 35 | 233 | 5 | M11788 | |
| Coexpression | CUI_TCF21_TARGETS_2_UP | CFH RELN CELF4 HUNK CFHR4 C1QL1 ELAPOR1 SRPX SEMA3C FRAS1 POLD1 FAT3 LAMA2 LAMA4 LHFPL2 | 1.55e-05 | 455 | 233 | 15 | MM1189 |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 1.60e-05 | 36 | 233 | 5 | MM1212 | |
| Coexpression | BOQUEST_STEM_CELL_UP | CFH FAT1 FBN1 CHRDL1 C3 SRPX SEMA3C AOX1 LAMA2 PDE4DIP PCOLCE2 | 2.40e-05 | 261 | 233 | 11 | M1834 |
| Coexpression | BANG_VERTEPORFIN_ENDOMETRIAL_CANCER_CELLS_UP | 2.64e-05 | 20 | 233 | 4 | M45002 | |
| Coexpression | BANG_VERTEPORFIN_ENDOMETRIAL_CANCER_CELLS_UP | 2.64e-05 | 20 | 233 | 4 | MM1336 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | MYCBP2 MYO10 FOXN3 ADAM10 AHDC1 FAT1 NFATC3 UGCG MKLN1 TMEM131L ASCC3 NCOA2 ATRN SEMA3C DMXL2 DUSP1 CRY1 IGF2R TIAM1 LHFPL2 CCN2 | 2.89e-05 | 856 | 233 | 21 | M4500 |
| Coexpression | SMID_BREAST_CANCER_NORMAL_LIKE_UP | CFH RELN FOXN3 ARID5A MEOX2 HOXA7 NRXN2 CHRDL1 C3 SRPX FHL1 LAMA2 LAMA4 AQP1 PRKCQ | 3.24e-05 | 485 | 233 | 15 | M8513 |
| Coexpression | CAIRO_LIVER_DEVELOPMENT_DN | 3.60e-05 | 225 | 233 | 10 | M6175 | |
| Coexpression | NIKOLSKY_BREAST_CANCER_20P13_AMPLICON | 3.76e-05 | 8 | 233 | 3 | M6821 | |
| Coexpression | CUI_TCF21_TARGETS_2_UP | CFH RELN CELF4 HUNK C1QL1 ELAPOR1 SRPX SEMA3C FRAS1 POLD1 FAT3 LAMA2 LAMA4 LHFPL2 | 4.08e-05 | 437 | 233 | 14 | M1610 |
| Coexpression | BAELDE_DIABETIC_NEPHROPATHY_DN | KLK6 PSMA6 PTH1R FAT1 NFATC3 NECTIN2 UGCG COL4A6 SEMA3C DUSP1 CAPN2 PDE4DIP CCN2 AGRN | 4.08e-05 | 437 | 233 | 14 | M4665 |
| Coexpression | SWEET_LUNG_CANCER_KRAS_DN | CFH CYP2A13 CFHR4 STAB1 MEOX2 C3 FHL1 SEMA3C POLD1 DUSP1 LAMA2 AQP1 TIAM1 GNB4 | 4.84e-05 | 444 | 233 | 14 | MM1051 |
| Coexpression | DESCARTES_FETAL_KIDNEY_STROMAL_CELLS | 5.08e-05 | 146 | 233 | 8 | M40222 | |
| Coexpression | SENESE_HDAC1_AND_HDAC2_TARGETS_DN | CADM3 NRXN3 RBMS3 PRRT3 ELAPOR1 TMEM131L DUSP1 AQP1 QPRT CNKSR3 | 5.77e-05 | 238 | 233 | 10 | M12004 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_LATE_MESOTHELIAL_CELL | CFH CLSTN3 GALE NCAM2 CHRDL1 C3 COL4A6 SEMA3C FRAS1 SHROOM3 AOX1 CDCP1 AQP1 CLIP4 ADAM33 PCOLCE2 TNFAIP3 AGRN | 6.47e-05 | 704 | 233 | 18 | M45672 |
| Coexpression | TRAVAGLINI_LUNG_ADVENTITIAL_FIBROBLAST_CELL | CFH CADM3 IGSF10 FBN1 CHRDL1 C3 SRPX SEMA3C DUSP1 AOX1 PCOLCE2 | 7.49e-05 | 296 | 233 | 11 | M41675 |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_TREATED_STAT3_KO_CD4_TCELL_UP | 7.73e-05 | 199 | 233 | 9 | M7474 | |
| Coexpression | CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN | RELN ADAM10 FAT1 NRXN3 FHL1 EFCAB6 RBMS2 AOX1 CLIC6 LCN2 CLSTN1 RGS12 CNKSR3 | 7.91e-05 | 407 | 233 | 13 | M2214 |
| Coexpression | GSE36826_WT_VS_IL1R_KO_SKIN_STAPH_AUREUS_INF_DN | 8.04e-05 | 200 | 233 | 9 | M9533 | |
| Coexpression | GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY3_DN | CADM3 MYCBP2 TMEM131L IL31RA L1CAM CDCP1 RGS12 CSF1R PDE4DIP | 8.04e-05 | 200 | 233 | 9 | M8486 |
| Coexpression | GSE3982_DC_VS_BASOPHIL_UP | 8.04e-05 | 200 | 233 | 9 | M5472 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | MYCBP2 MYO10 FOXN3 ADAM10 FAT1 UGCG MKLN1 ASCC3 SEMA3C DUSP1 CRY1 TIAM1 LHFPL2 CCN2 | 8.10e-05 | 466 | 233 | 14 | M13522 |
| Coexpression | DESCARTES_FETAL_LIVER_STELLATE_CELLS | 9.68e-05 | 160 | 233 | 8 | M40233 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | CFH ADAM9 PTH1R MELTF FBN1 SLCO1C1 RBMS3 JAG1 NECTIN2 KCNK3 SRPX GPR4 RBMS2 LAMA2 LAMA4 ADAM12 ARAP3 TNFAIP3 AGRN | 9.85e-05 | 795 | 233 | 19 | M39050 |
| Coexpression | ONDER_CDH1_SIGNALING_VIA_CTNNB1 | 1.05e-04 | 84 | 233 | 6 | M15484 | |
| Coexpression | TRAVAGLINI_LUNG_ALVEOLAR_FIBROBLAST_CELL | 1.15e-04 | 164 | 233 | 8 | M41676 | |
| Coexpression | KRIEG_HYPOXIA_NOT_VIA_KDM3A | FOXN3 ZNF229 ADAM10 ARID5A SLC39A13 C1QL1 MKLN1 FHL1 ALDOA USP1 DUSP1 SLC43A3 TXNRD2 CDCP1 THOC6 LHFPL2 CCN2 TNFAIP3 | 1.34e-04 | 746 | 233 | 18 | M2469 |
| Coexpression | LI_CISPLATIN_RESISTANCE_DN | 2.03e-04 | 33 | 233 | 4 | M10150 | |
| Coexpression | WILCOX_RESPONSE_TO_PROGESTERONE_DN | 2.28e-04 | 62 | 233 | 5 | M16774 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_ILCP_CELL | 2.35e-04 | 182 | 233 | 8 | M45771 | |
| Coexpression | BROWNE_HCMV_INFECTION_18HR_DN | 2.35e-04 | 182 | 233 | 8 | M6641 | |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G3 | 2.35e-04 | 14 | 233 | 3 | M8463 | |
| Coexpression | DELYS_THYROID_CANCER_DN | 2.54e-04 | 233 | 233 | 9 | M13273 | |
| Coexpression | FOROUTAN_PRODRANK_TGFB_EMT_UP | 2.62e-04 | 185 | 233 | 8 | M42503 | |
| Coexpression | SMID_BREAST_CANCER_LUMINAL_B_DN | KLK6 MEOX2 FAT1 CHRDL1 C3 SRPX FHL1 L1CAM GRB14 SLC43A3 LCN2 AQP1 PCOLCE2 CCN2 TNFAIP3 | 2.66e-04 | 587 | 233 | 15 | M17572 |
| Coexpression | KIM_GLIS2_TARGETS_UP | 3.06e-04 | 102 | 233 | 6 | MM1064 | |
| Coexpression | KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS | 3.19e-04 | 37 | 233 | 4 | M5040 | |
| Coexpression | FOROUTAN_TGFB_EMT_UP | 3.37e-04 | 192 | 233 | 8 | M42501 | |
| Coexpression | KATSANOU_ELAVL1_TARGETS_DN | 3.56e-04 | 147 | 233 | 7 | M2387 | |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_POLYSACCHARIDE_ANTIBODY_CORRELATION_PROFILE_3DY_DN | 3.56e-04 | 16 | 233 | 3 | M40964 | |
| Coexpression | P53_DN.V2_UP | 3.71e-04 | 148 | 233 | 7 | M2694 | |
| Coexpression | GSE22611_UNSTIM_VS_2H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_UP | 3.73e-04 | 195 | 233 | 8 | M8151 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CADM3 RELN CELF4 MYCBP2 FRS3 MDGA2 FOXN3 AHDC1 NRXN3 NRXN2 RBMS3 UGCG HERC1 SEMA3C L1CAM SHROOM2 SLC32A1 TRIM9 NCAN PDE4DIP PCOLCE2 MUC2 | 3.79e-04 | 1106 | 233 | 22 | M39071 |
| Coexpression | GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_UP | 3.86e-04 | 196 | 233 | 8 | M4972 | |
| Coexpression | PLASARI_TGFB1_TARGETS_10HR_UP | 3.86e-04 | 196 | 233 | 8 | M2445 | |
| Coexpression | PLASARI_TGFB1_TARGETS_10HR_UP | 4.00e-04 | 197 | 233 | 8 | MM1320 | |
| Coexpression | MAHAJAN_RESPONSE_TO_IL1A_DN | 4.02e-04 | 70 | 233 | 5 | M12107 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2 | CFH PTH1R RBMS3 LAMA2 LAMA4 SLC43A3 ADAM12 TGFB1I1 ADAM33 AGRN | 4.08e-04 | 303 | 233 | 10 | M39040 |
| Coexpression | WEST_ADRENOCORTICAL_TUMOR_DN | CFH PTH1R STAB1 RBMS3 KCNK3 CHRDL1 C3 FHL1 FOXC2 DUSP1 AOX1 LAMA2 MUC2 RPL5 | 4.11e-04 | 546 | 233 | 14 | M3837 |
| Coexpression | GSE14308_TH2_VS_NATURAL_TREG_DN | 4.27e-04 | 199 | 233 | 8 | M3369 | |
| Coexpression | GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP | 4.27e-04 | 199 | 233 | 8 | M9330 | |
| Coexpression | GSE10273_HIGH_VS_LOW_IL7_TREATED_IRF4_8_NULL_PRE_BCELL_DN | 4.27e-04 | 199 | 233 | 8 | M316 | |
| Coexpression | GSE3982_MAC_VS_NKCELL_UP | 4.27e-04 | 199 | 233 | 8 | M5508 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_BCELL_UP | 4.27e-04 | 199 | 233 | 8 | M5406 | |
| Coexpression | SWEET_LUNG_CANCER_KRAS_DN | CFH STAB1 MEOX2 C3 FHL1 SEMA3C POLD1 DUSP1 LAMA2 AQP1 TIAM1 GNB4 | 4.28e-04 | 422 | 233 | 12 | M7396 |
| Coexpression | TOMLINS_PROSTATE_CANCER_DN | 4.33e-04 | 40 | 233 | 4 | M11504 | |
| Coexpression | GSE369_PRE_VS_POST_IL6_INJECTION_SOCS3_KO_LIVER_DN | 4.42e-04 | 200 | 233 | 8 | M5977 | |
| Coexpression | GSE28737_BCL6_HET_VS_BCL6_KO_MARGINAL_ZONE_BCELL_DN | 4.42e-04 | 200 | 233 | 8 | M9349 | |
| Coexpression | GSE8685_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_DN | 4.42e-04 | 200 | 233 | 8 | M327 | |
| Coexpression | GSE27786_LIN_NEG_VS_CD4_TCELL_DN | 4.42e-04 | 200 | 233 | 8 | M4773 | |
| Coexpression | GSE18893_CTRL_VS_TNF_TREATED_TCONV_2H_UP | 4.42e-04 | 200 | 233 | 8 | M7295 | |
| Coexpression | GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_UP | 4.42e-04 | 200 | 233 | 8 | M4966 | |
| Coexpression | GSE12392_WT_VS_IFNB_KO_CD8A_NEG_SPLEEN_DC_DN | 4.42e-04 | 200 | 233 | 8 | M7150 | |
| Coexpression | GSE3691_CONVENTIONAL_VS_PLASMACYTOID_DC_SPLEEN_DN | 4.42e-04 | 200 | 233 | 8 | M6368 | |
| Coexpression | GSE4142_NAIVE_VS_MEMORY_BCELL_DN | 4.42e-04 | 200 | 233 | 8 | M6389 | |
| Coexpression | GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_DN | 4.42e-04 | 200 | 233 | 8 | M6358 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 4.42e-04 | 200 | 233 | 8 | M5930 | |
| Coexpression | HALLMARK_APICAL_JUNCTION | 4.42e-04 | 200 | 233 | 8 | M5915 | |
| Coexpression | GSE23925_DARK_ZONE_VS_NAIVE_BCELL_DN | 4.42e-04 | 200 | 233 | 8 | M7881 | |
| Coexpression | FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_ENDOTHELIAL | RBMS3 BSG JAG1 NECTIN2 CAPN2 LAMA2 LAMA4 SLC43A3 TGFB1I1 MFSD2A AGRN | 4.57e-04 | 365 | 233 | 11 | M39018 |
| Coexpression | WOOD_EBV_EBNA1_TARGETS_UP | 4.59e-04 | 110 | 233 | 6 | M1696 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_UP | 4.72e-04 | 202 | 233 | 8 | M38982 | |
| Coexpression | KAAB_HEART_ATRIUM_VS_VENTRICLE_UP | 5.04e-04 | 256 | 233 | 9 | M10952 | |
| Coexpression | ZHONG_PFC_MAJOR_TYPES_INTERNEURON | 5.13e-04 | 18 | 233 | 3 | M39076 | |
| Coexpression | ONDER_CDH1_TARGETS_2_UP | 5.18e-04 | 257 | 233 | 9 | M13867 | |
| Coexpression | JOHNSTONE_PARVB_TARGETS_3_UP | ITGB4 MELTF JAG1 UGCG C3 SRPX FRAS1 L1CAM CDCP1 CLIP4 IGF2R AGRN | 5.37e-04 | 433 | 233 | 12 | M2240 |
| Coexpression | KATSANOU_ELAVL1_TARGETS_DN | 5.49e-04 | 158 | 233 | 7 | MM934 | |
| Coexpression | ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE | 5.88e-04 | 76 | 233 | 5 | M1685 | |
| Coexpression | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 | RELN CELF4 MYCBP2 C1QL1 NRXN2 KCNK15 HSD11B2 FOXC2 L1CAM SLC32A1 PDE4DIP GNB4 | 5.94e-04 | 438 | 233 | 12 | M1954 |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | CFH RELN STAB1 MEOX2 PLEKHG1 FBN1 JAG1 NECTIN2 C3 PLCD1 FOXC2 ASAH2 DUSP1 LAMA4 SLC43A3 LCN2 AQP1 ARAP3 HMCN1 LHFPL2 AGRN | 1.81e-08 | 450 | 227 | 21 | GSM777063_500 |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | CFH RELN STAB1 MEOX2 PLEKHG1 FBN1 JAG1 NECTIN2 C3 PLCD1 FOXC2 ASAH2 DUSP1 LAMA4 SLC43A3 ARAP3 HMCN1 LHFPL2 AGRN | 2.85e-07 | 439 | 227 | 19 | GSM777059_500 |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | CFH MEOX2 IGSF10 FAT1 FBN1 RBMS3 JAG1 CHRDL1 C3 SRPX FHL1 DUSP1 LAMA2 LAMA4 SLC43A3 AQP1 PCOLCE2 CCN2 | 2.01e-06 | 453 | 227 | 18 | GSM777067_500 |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | CFH SCARF2 MEOX2 IGSF10 FAT1 FBN1 RBMS3 CHRDL1 C3 SRPX DUSP1 LAMA2 LAMA4 SLC43A3 AQP1 ADAM12 HMCN1 PCOLCE2 | 2.98e-06 | 466 | 227 | 18 | GSM777050_500 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | CFH LRRTM3 HUNK PTH1R IGSF10 ZIK1 FBN1 FBN2 RBMS3 JAG1 HSD11B2 SEMA3C FRAS1 FAT3 LAMA2 SLC43A3 ADAM12 CRY1 IGF2R HMCN1 SHCBP1 LHFPL2 LIX1 | 1.08e-05 | 777 | 227 | 23 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | CADM3 MEOX2 IGSF10 FBN1 CHRDL1 C3 SRPX FHL1 SEMA3C DUSP1 LAMA2 LAMA4 SLC43A3 AQP1 HMCN1 PCOLCE2 | 2.07e-05 | 437 | 227 | 16 | GSM777046_500 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | USP11 ZIK1 FBN1 FBN2 RBMS3 SEMA3C FRAS1 FAT3 CRY1 IGF2R ALX1 HMCN1 SHCBP1 LHFPL2 | 2.98e-05 | 354 | 227 | 14 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | CFH USP11 IGSF10 ZIK1 FBN1 FBN2 HSD11B2 SEMA3C FAT3 LAMA2 CRY1 HMCN1 SHCBP1 | 3.15e-05 | 310 | 227 | 13 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | CFH MEOX2 IGSF10 FAT1 FBN1 RBMS3 JAG1 CHRDL1 C3 SRPX DUSP1 LAMA4 SLC43A3 AQP1 ADAM12 PCOLCE2 | 3.37e-05 | 455 | 227 | 16 | GSM777055_500 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#2_top-relative-expression-ranked_1000 | ADCY5 CHRDL1 C1QTNF2 SRPX FHL1 COL4A6 FAT3 CLIC6 LCN2 QPRT GNB4 | 3.95e-05 | 230 | 227 | 11 | gudmap_developingGonad_P2_epididymis_1000_k2 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5 | CADM3 CELF4 MYO10 USP11 NCAM2 MDGA2 GCDH FOXN3 USP20 SLC39A13 FAT1 NRXN3 NRXN2 FHL1 ATRN FAT3 HECTD4 MFSD2A TRIM9 QPRT NCAN | 4.19e-05 | 732 | 227 | 21 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K5 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | CFH CENPB SLC25A30 ZNF229 ADCY5 RBMS3 CHRDL1 C3 C1QTNF2 SRPX HERC1 FHL1 SEC61A1 COL4A6 FAT3 LAMA2 CLIC6 LCN2 CSF1R QPRT LHFPL2 GNB4 | 4.86e-05 | 797 | 227 | 22 | gudmap_developingGonad_P2_epididymis_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | CFH USP11 IGSF10 FBN1 NRXN3 HSD11B2 SEMA3C FAT3 LAMA2 CRY1 IGF2R HMCN1 LHFPL2 | 7.17e-05 | 336 | 227 | 13 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | USP11 ZIK1 FBN1 FBN2 RBMS3 SEMA3C FAT3 CRY1 IGF2R ALX1 HMCN1 SHCBP1 LHFPL2 | 7.38e-05 | 337 | 227 | 13 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#3_top-relative-expression-ranked_1000 | RELN LRRTM3 ADCY5 JAG1 FHL1 FOXC2 FAT3 GRB14 CLIC6 TGFB1I1 IGF2R AGRN | 7.95e-05 | 293 | 227 | 12 | gudmap_kidney_P0_JuxtaGlom_Ren1_k3_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | CFH MYO10 USP11 HUNK IGSF10 FAT1 ZIK1 FBN1 FBN2 JAG1 HSD11B2 SEMA3C FAT3 LAMA2 GRB14 ADAM12 CRY1 DDIAS HMCN1 TIAM1 SHCBP1 | 8.29e-05 | 768 | 227 | 21 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000 | MYCBP2 ADCY5 ZIK1 FBN2 RBMS3 KCNK3 MKLN1 SRPX FHL1 NCOA2 SEMA3C AOX1 LAMA2 LAMA4 AQP1 IGF2R ALX1 LHFPL2 GNB4 CCN2 AGRN | 8.92e-05 | 772 | 227 | 21 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000 |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | CFH ADAM9 MEOX2 IGSF10 FAT1 FBN1 RBMS3 JAG1 C3 SRPX FHL1 DUSP1 LAMA2 LAMA4 SLC43A3 | 9.54e-05 | 445 | 227 | 15 | GSM777043_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000 | MYO10 MDGA2 STAB1 MEOX2 PLEKHG1 JAG1 ASAH2 DUSP1 CAPN2 LAMA4 GRB14 SLC43A3 SHROOM2 AQP1 ADAM12 ACTR2 ZDHHC20 ARAP3 CSF1R HMCN1 GNB4 TNFAIP3 | 1.18e-04 | 847 | 227 | 22 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500 | CFH USP11 IGSF10 FBN1 FBN2 JAG1 SEMA3C FAT3 LAMA2 GRB14 ADAM12 CRY1 HMCN1 | 1.28e-04 | 356 | 227 | 13 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_1000 | CFH RELN SCARF2 ADAM9 NCAM2 MEOX2 FBN1 C3 SRPX SPOCD1 FOXC2 GPR4 SEMA3C DUSP1 CAPN2 LAMA4 CDCP1 AQP1 ADAM12 TGFB1I1 HMCN1 PCOLCE2 CCN2 TNFAIP3 | 1.30e-04 | 975 | 227 | 24 | PCBC_ctl_CardiacMyocyte_1000 |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | MYO10 ADCY5 STAB1 MEOX2 PLEKHG1 JAG1 NECTIN2 DUSP1 LAMA4 SLC43A3 AQP1 ARAP3 LHFPL2 GNB4 CCN2 | 1.34e-04 | 459 | 227 | 15 | GSM777037_500 |
| CoexpressionAtlas | dev gonad_e11.5_F_ReproVasc_Flk_top-relative-expression-ranked_500 | MDGA2 STAB1 PLEKHG1 FOXC2 ASAH2 DUSP1 LAMA4 SLC43A3 SHROOM2 ADAM12 ARAP3 CSF1R HMCN1 TNFAIP3 | 1.39e-04 | 409 | 227 | 14 | gudmap_dev gonad_e11.5_F_ReproVasc_Flk_500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000 | CLSTN3 MYO10 NCAM2 MDGA2 IGSF10 NRXN3 NRXN2 EXOSC6 ELAPOR1 CHRDL1 SRPX FHL1 SHROOM3 RDH5 PPAT AQP1 VPS9D1 MFSD2A CSF1R QPRT NCAN ADAM33 MARVELD2 | 3.36e-04 | 976 | 227 | 23 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000 |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_Captopr_k-means-cluster#2_top-relative-expression-ranked_100 | 3.39e-04 | 3 | 227 | 2 | gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_k2_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000 | CYP2A13 SRI ADAM10 HP1BP3 TMEM179B EXOSC6 ELMOD3 EMC10 KEL USP1 RBM18 NCOA2 EFCAB6 ATG7 LAMA2 EIF4E1B VPS9D1 MFSD2A IGF2R ALX1 HMCN1 TIAM1 LIX1 | 3.82e-04 | 985 | 227 | 23 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000 |
| CoexpressionAtlas | kidney_e13.5_Podocyte_MafB_k-means-cluster#1_top-relative-expression-ranked_100 | 4.02e-04 | 14 | 227 | 3 | gudmap_kidney_e13.5_Podocyte_MafB_k1_100 | |
| CoexpressionAtlas | Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5 | MYO10 ADCY5 STAB1 PLEKHG1 JAG1 NECTIN2 ASAH2 DUSP1 LAMA4 SLC43A3 AQP1 ARAP3 LHFPL2 GNB4 | 4.20e-04 | 456 | 227 | 14 | GSM777032_500 |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | CFH NCAM2 MEOX2 FBN1 RBMS3 FHL1 HMGCLL1 FRAS1 FAT3 AOX1 LAMA2 LAMA4 HMCN1 CCN2 | 1.82e-12 | 191 | 233 | 14 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | CFH NCAM2 MEOX2 IGSF10 FBN1 CHRDL1 FHL1 HMGCLL1 FAT3 AOX1 LAMA2 LAMA4 HMCN1 CCN2 | 2.58e-12 | 196 | 233 | 14 | 42e9828222a9663525d571633e8a454c30bfa7f8 |
| ToppCell | Skin-Fibroblasts|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | CFH CADM3 SCARF2 IGSF10 FBN1 RBMS3 CHRDL1 C3 AOX1 LAMA2 LAMA4 LHFPL2 ADAM33 PCOLCE2 | 3.40e-12 | 200 | 233 | 14 | f777eadf571a1a6d246da87346a9cb9d511c2e81 |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | CFH CADM3 IGSF10 FBN1 CHRDL1 C3 SRPX FHL1 SEMA3C AOX1 LAMA2 LAMA4 ADAM33 PCOLCE2 | 3.40e-12 | 200 | 233 | 14 | 6f7f015b5fa1f52374f2c7d9ba339012395eda5f |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | CFH MEOX2 FBN1 RBMS3 CHRDL1 C1QTNF2 SRPX FHL1 AOX1 LAMA2 LAMA4 HMCN1 CCN2 | 1.04e-11 | 176 | 233 | 13 | 510f9a14dc1c151d24d079e0cc004cdf4f86336c |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | MYO10 NCAM2 PTH1R MEOX2 IGSF10 FBN1 FHL1 HMGCLL1 FRAS1 FAT3 LAMA2 LAMA4 HMCN1 | 1.48e-11 | 181 | 233 | 13 | 9ede19228ba5c0668a9c06c915510b95585216ef |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | CFH SCARF2 MEOX2 IGSF10 FBN1 RBMS3 C1QTNF2 SRPX FHL1 SHROOM3 LAMA2 LAMA4 PCOLCE2 | 2.91e-11 | 191 | 233 | 13 | ce80f65bd24b1c4d2152bf45248449e7a1a97e56 |
| ToppCell | facs-Lung-24m-Mesenchymal|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | CFH SCARF2 MEOX2 FBN1 RBMS3 CHRDL1 C3 C1QTNF2 SRPX FHL1 LAMA2 LAMA4 PCOLCE2 | 2.91e-11 | 191 | 233 | 13 | ba02cbdfda6a94374a6472eb88499059979af472 |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | CFH SCARF2 MEOX2 FBN1 RBMS3 CHRDL1 C3 C1QTNF2 SRPX FHL1 LAMA2 LAMA4 PCOLCE2 | 2.91e-11 | 191 | 233 | 13 | 094c9d3270fc1e487ccf10fb4936af5f081f6009 |
| ToppCell | droplet-Lung-1m-Mesenchymal|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | CFH SCARF2 MEOX2 IGSF10 FBN1 RBMS3 C1QTNF2 SRPX FHL1 SHROOM3 LAMA2 LAMA4 PCOLCE2 | 3.11e-11 | 192 | 233 | 13 | 01433bd4794b8bcc51fe4249124a0f4289b9d6e2 |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | CFH NCAM2 MEOX2 FBN1 RBMS3 FHL1 HMGCLL1 FRAS1 FAT3 AOX1 LAMA2 LAMA4 HMCN1 | 3.11e-11 | 192 | 233 | 13 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | MYO10 NCAM2 PTH1R MEOX2 FBN1 RBMS3 FHL1 HMGCLL1 FAT3 AOX1 LAMA2 LAMA4 HMCN1 | 3.31e-11 | 193 | 233 | 13 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | NCAM2 PTH1R MEOX2 IGSF10 FBN1 FHL1 HMGCLL1 FAT3 AOX1 LAMA2 LAMA4 HMCN1 CCN2 | 3.77e-11 | 195 | 233 | 13 | aa0add081881d349099d12efca5cdee098038d4e |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | NCAM2 MEOX2 IGSF10 FBN1 CHRDL1 FHL1 HMGCLL1 FAT3 AOX1 LAMA2 LAMA4 HMCN1 CCN2 | 3.77e-11 | 195 | 233 | 13 | df409f94f4e83be89f7a608058ee07ce3ce3a149 |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | NCAM2 MEOX2 IGSF10 FBN1 CHRDL1 FHL1 HMGCLL1 FAT3 AOX1 LAMA2 LAMA4 HMCN1 CCN2 | 3.77e-11 | 195 | 233 | 13 | 4243190ad291d56694e2155954dbaa879c9d3844 |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | CFH NCAM2 MEOX2 FBN1 RBMS3 CHRDL1 HMGCLL1 FAT3 AOX1 LAMA2 LAMA4 HMCN1 CCN2 | 4.02e-11 | 196 | 233 | 13 | 7d8505dac15fa59935ccf592afc54b04c4c6554f |
| ToppCell | tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lung / Location, Cell class and cell subclass | CFH NCAM2 MEOX2 FBN1 RBMS3 CHRDL1 C3 C1QTNF2 FHL1 HMGCLL1 LAMA2 LAMA4 CCN2 | 4.57e-11 | 198 | 233 | 13 | 2d7842f352273b6b823c86eb548b9f4a4cddf0ae |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | CFH NCAM2 MEOX2 IGSF10 FBN1 CHRDL1 FHL1 FAT3 AOX1 LAMA2 LAMA4 HMCN1 CCN2 | 4.57e-11 | 198 | 233 | 13 | f1374f7a50244d59c766ac41f44c08c9117407d2 |
| ToppCell | (5)_Fibroblast-F|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | CADM3 FBN1 NRXN2 RBMS3 CHRDL1 C3 C1QTNF2 SEMA3C AOX1 LAMA2 LAMA4 ADAM33 PCOLCE2 | 4.86e-11 | 199 | 233 | 13 | 1f66db4f502de4a5159cde90fcb3befb26b8d375 |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | CFH NCAM2 MEOX2 IGSF10 RBMS3 CHRDL1 HMGCLL1 FRAS1 FAT3 LAMA2 LAMA4 HMCN1 CCN2 | 5.18e-11 | 200 | 233 | 13 | aa1a35dcca3b799241eef4237f6eb94660e019f0 |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | CFH NCAM2 MEOX2 IGSF10 RBMS3 CHRDL1 HMGCLL1 FRAS1 FAT3 LAMA2 LAMA4 HMCN1 CCN2 | 5.18e-11 | 200 | 233 | 13 | a510deaada669e690329183e18df02870bd204b3 |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | CFH MEOX2 FBN1 RBMS3 C3 SRPX FHL1 HMGCLL1 AOX1 LAMA2 LAMA4 HMCN1 ADAM33 | 5.18e-11 | 200 | 233 | 13 | b4ccffdd79526c85e5273d27b668dbddcddba1ee |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | CFH MEOX2 FBN1 RBMS3 CHRDL1 C3 SRPX FHL1 AOX1 LAMA2 LAMA4 ADAM33 PCOLCE2 | 5.18e-11 | 200 | 233 | 13 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | CFH CADM3 FBN1 RBMS3 CHRDL1 C3 SRPX FHL1 AOX1 LAMA2 LAMA4 ADAM33 PCOLCE2 | 5.18e-11 | 200 | 233 | 13 | 933b5b400e48a511ba0a056be1d33d3610b5f10d |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | CFH SCARF2 NCAM2 MEOX2 IGSF10 FBN1 CHRDL1 HMGCLL1 FRAS1 FAT3 LAMA2 LAMA4 HMCN1 | 5.18e-11 | 200 | 233 | 13 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | CFH CADM3 IGSF10 FBN1 CHRDL1 C3 SRPX FHL1 SEMA3C AOX1 LAMA2 LAMA4 PCOLCE2 | 5.18e-11 | 200 | 233 | 13 | 3a164e3971bcd62b148b813171c103adb81f972e |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | CFH NCAM2 MEOX2 FBN1 RBMS3 FHL1 HMGCLL1 FAT3 AOX1 LAMA2 LAMA4 HMCN1 ADAM33 | 5.18e-11 | 200 | 233 | 13 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | CFH NCAM2 MEOX2 IGSF10 RBMS3 CHRDL1 HMGCLL1 FRAS1 FAT3 LAMA2 LAMA4 HMCN1 CCN2 | 5.18e-11 | 200 | 233 | 13 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | CFH CADM3 FBN1 CHRDL1 C3 SRPX FHL1 SEMA3C LAMA2 ADAM33 PCOLCE2 CCN2 | 1.37e-10 | 173 | 233 | 12 | 11e95a60b5f6f07f27154a23203bac431e7528c6 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RELN NCAM2 MDGA2 CAPN8 MELTF FAT1 FBN2 FRAS1 ZAN EFCAB6 FAT3 HMCN1 | 2.79e-10 | 184 | 233 | 12 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RELN NCAM2 MDGA2 CAPN8 MELTF FAT1 FBN2 FRAS1 ZAN EFCAB6 FAT3 HMCN1 | 2.79e-10 | 184 | 233 | 12 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RELN NCAM2 MDGA2 CAPN8 MELTF FAT1 FBN2 FRAS1 ZAN EFCAB6 FAT3 HMCN1 | 2.79e-10 | 184 | 233 | 12 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | CFH NCAM2 MEOX2 IGSF10 FBN1 CHRDL1 FHL1 AOX1 LAMA2 LAMA4 HMCN1 CCN2 | 3.16e-10 | 186 | 233 | 12 | 5473283fb95cee556b1f6934cf72169b676b5bcc |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | NCAM2 MEOX2 FBN1 RBMS3 FHL1 HMGCLL1 FRAS1 FAT3 LAMA2 LAMA4 HMCN1 CCN2 | 3.36e-10 | 187 | 233 | 12 | 92d468dde81125d51daf7abd4703741abe1ab91c |
| ToppCell | facs-Lung-18m-Mesenchymal|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | CFH SCARF2 MEOX2 FBN1 RBMS3 CHRDL1 C3 SRPX FHL1 LAMA2 LAMA4 PCOLCE2 | 3.80e-10 | 189 | 233 | 12 | bdf8db938aa0863c4fed6fa99dcffd63c8c20c31 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | MYO10 NCAM2 MEOX2 IGSF10 FHL1 HMGCLL1 FRAS1 FAT3 LAMA2 LAMA4 HMCN1 TIAM1 | 3.80e-10 | 189 | 233 | 12 | 203c80030df08ae112f9ae4043709f455d87ce89 |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | CFH NCAM2 MEOX2 FBN1 RBMS3 FHL1 FAT3 AOX1 LAMA2 LAMA4 HMCN1 CCN2 | 4.03e-10 | 190 | 233 | 12 | 3a42a9b98d954685d38a741f44545898d0e3e9ce |
| ToppCell | droplet-Lung-18m-Mesenchymal|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | CFH SCARF2 MEOX2 IGSF10 FBN1 RBMS3 C1QTNF2 FHL1 LAMA2 LAMA4 PCOLCE2 CCN2 | 4.03e-10 | 190 | 233 | 12 | 0b7200897b2c389632c9b1ee37e272b811555dbc |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CFH SCARF2 MEOX2 IGSF10 FBN1 RBMS3 C1QTNF2 SRPX FHL1 LAMA2 LAMA4 PCOLCE2 | 4.03e-10 | 190 | 233 | 12 | 9cd147a174017ebda23cc47b6d4552d898acd092 |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | CFH SCARF2 MEOX2 IGSF10 FBN1 RBMS3 C3 SRPX FHL1 LAMA2 LAMA4 PCOLCE2 | 4.29e-10 | 191 | 233 | 12 | 997abf0cc5873bed0372c4a333ed307fa72774d2 |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CFH SCARF2 MEOX2 FBN1 RBMS3 C1QTNF2 FHL1 SHROOM3 LAMA2 LAMA4 PCOLCE2 CCN2 | 4.55e-10 | 192 | 233 | 12 | df56c3e3bb1aafc1126607f4426554c09c8c40cf |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CFH CADM3 MEOX2 IGSF10 FBN1 C3 C1QTNF2 SRPX LAMA2 LAMA4 HMCN1 PCOLCE2 | 4.55e-10 | 192 | 233 | 12 | d2c03490c5e835d0f0a732803093c64b8d4b4029 |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | CFH SCARF2 MEOX2 IGSF10 FBN1 CHRDL1 C3 C1QTNF2 FHL1 AOX1 LAMA2 ADAM33 | 4.55e-10 | 192 | 233 | 12 | c5f8e766453f87847b740d6988c524b3d0ef3765 |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | MYO10 NCAM2 PTH1R MEOX2 FBN1 FHL1 HMGCLL1 FRAS1 FAT3 LAMA2 LAMA4 HMCN1 | 4.83e-10 | 193 | 233 | 12 | acad568621ed677031797b8c2e34dafea798d681 |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | MYO10 MEOX2 FBN1 RBMS3 CHRDL1 FHL1 HMGCLL1 FAT3 AOX1 LAMA2 LAMA4 PDE4DIP | 5.13e-10 | 194 | 233 | 12 | e93de9428c986b8943fc169258847c650cfab0e5 |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CADM3 RELN SCARF2 PTH1R IGSF10 NRXN3 RBMS3 C1QTNF2 FHL1 LAMA2 TGFB1I1 CCN2 | 5.13e-10 | 194 | 233 | 12 | 7942bc83c1bdca687795b91aa232824d603f9b09 |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CADM3 RELN SCARF2 PTH1R IGSF10 NRXN3 RBMS3 C1QTNF2 FHL1 LAMA2 TGFB1I1 CCN2 | 5.13e-10 | 194 | 233 | 12 | 415801a3dfacf05f2b603fb424df3d045190a812 |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CADM3 RELN SCARF2 PTH1R IGSF10 NRXN3 RBMS3 C1QTNF2 FHL1 LAMA2 TGFB1I1 CCN2 | 5.13e-10 | 194 | 233 | 12 | 256cb33ec90328f2704921fb0fe0fd9812e138b0 |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SCARF2 MEOX2 FBN1 RBMS3 KCNK3 C1QTNF2 SRPX FHL1 SHROOM3 LAMA2 LAMA4 PCOLCE2 | 5.13e-10 | 194 | 233 | 12 | d47e3c7b22444aef0c7a37bc8cd8853b590a56dd |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | MYO10 NCAM2 MEOX2 FBN1 RBMS3 FHL1 HMGCLL1 FRAS1 FAT3 LAMA2 LAMA4 HMCN1 | 5.44e-10 | 195 | 233 | 12 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | CFH CADM3 RELN KLK6 C1QL1 FAT1 UGCG DUSP1 RGS12 MFSD2A CCN2 LIX1 | 5.77e-10 | 196 | 233 | 12 | 34e79918a448f6c19b87e1b1ce13c012b24be1f8 |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | CFH CADM3 RELN KLK6 C1QL1 FAT1 UGCG DUSP1 RGS12 MFSD2A CCN2 LIX1 | 5.77e-10 | 196 | 233 | 12 | 8f82e01ca50aa4cd6149547505b4474a02fad618 |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | CFH CADM3 RELN KLK6 C1QL1 FAT1 CHRDL1 C3 FOXC2 TGFB1I1 CCN2 LIX1 | 5.77e-10 | 196 | 233 | 12 | 023477a499a2c190f363cfdbc9d9c646733a6541 |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | NCAM2 PTH1R MEOX2 IGSF10 FBN1 RBMS3 FHL1 FAT3 AOX1 LAMA2 LAMA4 HMCN1 | 5.77e-10 | 196 | 233 | 12 | bc94909f9b2dc08a59eef1914148b69720569c8f |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | CFH CADM3 RELN KLK6 C1QL1 FAT1 CHRDL1 C3 FOXC2 TGFB1I1 CCN2 LIX1 | 5.77e-10 | 196 | 233 | 12 | 3cb74f1a333a82cac2b459f2f1517e2acf22b5fd |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|normal_Lung / Location, Cell class and cell subclass | CFH NCAM2 MEOX2 IGSF10 CHRDL1 C1QTNF2 FHL1 HMGCLL1 FAT3 LAMA4 HMCN1 CCN2 | 6.11e-10 | 197 | 233 | 12 | 6c57ab2efb8363828e24211c4d45e58bb73a9a4d |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | SCARF2 NCAM2 MEOX2 IGSF10 CHRDL1 C1QTNF2 FHL1 FAT3 LAMA2 LAMA4 HMCN1 CCN2 | 6.11e-10 | 197 | 233 | 12 | 13896ec65ccda0b928c91d41112dc01b480036b7 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | CFH PTH1R RBMS3 HSD11B2 FOXC2 GPR4 LAMA4 PPEF1 ADAM12 TGFB1I1 CCN2 AGRN | 6.11e-10 | 197 | 233 | 12 | 983502a99e6d59bb36225b0246a9990604de1a01 |
| ToppCell | background-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.48e-10 | 198 | 233 | 12 | 79f32f965aed6a10c5cb803173e3db7b32e07a91 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | CFH NCAM2 MEOX2 FBN1 RBMS3 HMGCLL1 FAT3 AOX1 LAMA2 LAMA4 HMCN1 CCN2 | 6.48e-10 | 198 | 233 | 12 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 |
| ToppCell | 368C-Fibroblasts|368C / Donor, Lineage, Cell class and subclass (all cells) | CFH CADM3 FBN1 CHRDL1 C3 SRPX FHL1 AOX1 LAMA2 LAMA4 TGFB1I1 CCN2 | 6.86e-10 | 199 | 233 | 12 | dbf64b83e2dc311b68f299c3f306ee098efd664c |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | CFH CADM3 MEOX2 IGSF10 FBN1 CHRDL1 C3 FHL1 AOX1 LAMA2 LAMA4 ADAM33 | 6.86e-10 | 199 | 233 | 12 | 0019cfaa586a450c2e4952d1184a540561c8d0ba |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | CFH NCAM2 MEOX2 IGSF10 FBN1 CHRDL1 FHL1 FAT3 LAMA2 LAMA4 HMCN1 CCN2 | 6.86e-10 | 199 | 233 | 12 | 66a79732caf2f04c09b4d9832377aa01ca477677 |
| ToppCell | 343B-Fibroblasts|343B / Donor, Lineage, Cell class and subclass (all cells) | CFH MEOX2 FBN1 RBMS3 CHRDL1 C1QTNF2 FHL1 AOX1 LAMA2 LAMA4 TGFB1I1 CCN2 | 7.27e-10 | 200 | 233 | 12 | 376c1a77031e090be96948b47c78ac0d393f5775 |
| ToppCell | normal_Lung-Fibroblasts|normal_Lung / Location, Cell class and cell subclass | CFH CADM3 IGSF10 FBN1 CHRDL1 C3 C1QTNF2 SRPX FHL1 AOX1 LAMA2 LAMA4 | 7.27e-10 | 200 | 233 | 12 | 803cf7f1382d07220249029cd220233232027689 |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | CFH NCAM2 MEOX2 FBN1 RBMS3 FHL1 FAT3 AOX1 LAMA2 LAMA4 HMCN1 ADAM33 | 7.27e-10 | 200 | 233 | 12 | 389cc775c8419d90fb77cd794376d2160a7bf44e |
| ToppCell | proximal-mesenchymal-Adventitial_Fibroblast-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | CFH CADM3 MEOX2 IGSF10 FBN1 CHRDL1 FHL1 AOX1 LAMA2 LAMA4 ADAM33 CCN2 | 7.27e-10 | 200 | 233 | 12 | 05486d86868f6a93429226063cca270f00dd8714 |
| ToppCell | proximal-3-mesenchymal-Adventitial_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | CFH CADM3 MEOX2 IGSF10 FBN1 CHRDL1 FHL1 AOX1 LAMA2 LAMA4 ADAM33 CCN2 | 7.27e-10 | 200 | 233 | 12 | 869d45b71efd395d050873db5fee2ed0443d5e6f |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | NCAM2 PTH1R MEOX2 FBN1 FHL1 HMGCLL1 FRAS1 FAT3 LAMA2 LAMA4 HMCN1 CCN2 | 7.27e-10 | 200 | 233 | 12 | 34f52003988ce6329d8deeee1ab875fa77e01e9d |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Fibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | CFH CADM3 MEOX2 IGSF10 FBN1 CHRDL1 C3 C1QTNF2 SRPX AOX1 LAMA2 ADAM33 | 7.27e-10 | 200 | 233 | 12 | 9996b6887cf2b1936e10a1aa396f09fd8da5f4c4 |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | CFH CADM3 FBN1 CHRDL1 C3 SRPX FHL1 SEMA3C AOX1 LAMA2 ADAM33 PCOLCE2 | 7.27e-10 | 200 | 233 | 12 | cfea2f9d85646c9b722150551ff2e8fc4f6cc98a |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | MYO10 NCAM2 PTH1R MEOX2 FBN1 FHL1 HMGCLL1 FRAS1 FAT3 LAMA2 LAMA4 HMCN1 | 7.27e-10 | 200 | 233 | 12 | e8462395fee0a532d1e7ec7f1795f28c42af6541 |
| ToppCell | proximal-mesenchymal-Adventitial_Fibroblast|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | CFH CADM3 MEOX2 IGSF10 FBN1 CHRDL1 FHL1 AOX1 LAMA2 LAMA4 ADAM33 CCN2 | 7.27e-10 | 200 | 233 | 12 | 58c5870030192b337e7d883044948634fcd17d2c |
| ToppCell | Tracheal-10x3prime_v2-Stromal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | CFH CADM3 FBN1 CHRDL1 C3 FHL1 AOX1 LAMA2 TGFB1I1 ADAM33 PCOLCE2 CCN2 | 7.27e-10 | 200 | 233 | 12 | f74b9b0e27afedd589e828d30194e8417029817a |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | NCAM2 MEOX2 FBN1 RBMS3 C3 SRPX FHL1 HMGCLL1 LAMA2 LAMA4 HMCN1 ADAM33 | 7.27e-10 | 200 | 233 | 12 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Fibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | CFH CADM3 FBN1 CHRDL1 C3 SRPX FHL1 AOX1 LAMA2 ADAM33 PCOLCE2 CCN2 | 7.27e-10 | 200 | 233 | 12 | 5fdca7959134a5c8e06e5d6d14aafe34b963aef2 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | CFH RELN MDGA2 FAT1 CFAP54 FBN2 DUSP1 CLIP4 MFSD2A CCN2 LIX1 | 3.29e-09 | 181 | 233 | 11 | 5f2d3a08577c440c944778d07aa993c6e7873f3d |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | CFH CADM3 ZNF229 ADCY5 FBN1 CHRDL1 COL4A6 AOX1 LAMA2 HMCN1 ADAM33 | 3.29e-09 | 181 | 233 | 11 | b116c68393d8836bac080f81a8fcbeb52e0403e7 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | CFH RELN MDGA2 FAT1 CFAP54 FBN2 DUSP1 CLIP4 MFSD2A CCN2 LIX1 | 3.29e-09 | 181 | 233 | 11 | c7c5f7d4c397b4613c772413a0a679377efffff3 |
| ToppCell | droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | STAB1 IGSF10 NRXN2 PCDHGA1 LAMA4 SLC43A3 AQP1 ATP1B4 ARAP3 TIAM1 LHFPL2 | 3.49e-09 | 182 | 233 | 11 | b1ec2015aad1181eac1bbf8d48ad6f2f7ed24a01 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.14e-09 | 185 | 233 | 11 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | PTH1R FBN1 FBN2 NRXN3 KCNK3 C1QTNF2 TGFB1I1 HMCN1 LHFPL2 GNB4 CCN2 | 4.14e-09 | 185 | 233 | 11 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.14e-09 | 185 | 233 | 11 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CFH SCARF2 IGSF10 FBN1 FBN2 SLCO1C1 C1QTNF2 SRPX LAMA2 HMCN1 PCOLCE2 | 4.38e-09 | 186 | 233 | 11 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.4.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | CADM3 FBN1 NRXN2 CHRDL1 C3 C1QTNF2 AOX1 LAMA2 LAMA4 ADAM33 PCOLCE2 | 4.38e-09 | 186 | 233 | 11 | 07d94d5d1c2fe7bb909a07ca81058a0eabc65c60 |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | CFH MEOX2 FBN1 CHRDL1 C3 SRPX FHL1 SEMA3C ADAM33 PCOLCE2 CCN2 | 4.90e-09 | 188 | 233 | 11 | 1cd5a4d744bd3777246958ea5eb94388a5cbad81 |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | CFH MEOX2 FBN1 CHRDL1 C3 SRPX FHL1 SEMA3C ADAM33 PCOLCE2 CCN2 | 4.90e-09 | 188 | 233 | 11 | c32d023a69b6da79687ff8fa7485e7499db57046 |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | CADM3 FBN1 NRXN2 CHRDL1 C3 FHL1 AOX1 LAMA2 LAMA4 ADAM33 PCOLCE2 | 4.90e-09 | 188 | 233 | 11 | e18065bbc26d6f3774fd1f478fb41d8fb555fa26 |
| ToppCell | droplet-Lung-immune-endo-depleted|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CFH SCARF2 MEOX2 IGSF10 FBN1 RBMS3 C1QTNF2 FHL1 LAMA2 LAMA4 PCOLCE2 | 5.18e-09 | 189 | 233 | 11 | c3fb363bb0156ffb3367c200f548faebda64ab4a |
| ToppCell | droplet-Lung-immune-endo-depleted-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CFH SCARF2 MEOX2 IGSF10 FBN1 RBMS3 C1QTNF2 FHL1 LAMA2 LAMA4 PCOLCE2 | 5.18e-09 | 189 | 233 | 11 | 2a2953f6b1b7d070d739dcaf7285fce6e097d9e4 |
| ToppCell | droplet-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | CFH SCARF2 MEOX2 IGSF10 FBN1 RBMS3 C1QTNF2 FHL1 LAMA2 LAMA4 PCOLCE2 | 5.18e-09 | 189 | 233 | 11 | 5a636e952da9b1fd26aa17f7b129054f2da322b5 |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | CFH SCARF2 MEOX2 FBN1 RBMS3 CHRDL1 C3 SRPX FHL1 LAMA2 PCOLCE2 | 5.18e-09 | 189 | 233 | 11 | 40cbd679dc0548bf5207e1b033c0597886ad6fe1 |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | CFH SCARF2 MEOX2 IGSF10 FBN1 RBMS3 C1QTNF2 FHL1 LAMA2 LAMA4 PCOLCE2 | 5.18e-09 | 189 | 233 | 11 | e76dc36a01d8ad7590b3acc4c46abfcb76857448 |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | CFH SCARF2 MEOX2 FBN1 RBMS3 C1QTNF2 FHL1 SHROOM3 LAMA2 LAMA4 PCOLCE2 | 5.78e-09 | 191 | 233 | 11 | 8a73d2df079566fca4cbb5cdb85721c2e87134c8 |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | SCARF2 MEOX2 IGSF10 FBN1 CHRDL1 SRPX FHL1 LAMA2 LAMA4 PCOLCE2 CCN2 | 5.78e-09 | 191 | 233 | 11 | cd497abed9e00e4e0becd9dbc036c6e7a60ae791 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | CFH NCAM2 MEOX2 IGSF10 FBN1 CHRDL1 C1QTNF2 SRPX FHL1 LAMA2 ADAM33 | 6.10e-09 | 192 | 233 | 11 | 8d56e360ebc624ca4cd7f0af4f3cc599c244f134 |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CFH CADM3 MEOX2 IGSF10 FBN1 C3 C1QTNF2 SRPX LAMA2 SLC43A3 PCOLCE2 | 6.10e-09 | 192 | 233 | 11 | 853a930e0641ffb50cbb4cef5837c70d75c3fc39 |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | CFH FBN1 RBMS3 C3 C1QTNF2 SRPX FHL1 SEMA3C LAMA2 LAMA4 PCOLCE2 | 6.10e-09 | 192 | 233 | 11 | 321850b0f881420c2d57d3e825e365c82fa511ab |
| ToppCell | droplet-Lung-30m-Mesenchymal|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | SCARF2 MEOX2 IGSF10 FBN1 CHRDL1 SRPX FHL1 LAMA2 LAMA4 PCOLCE2 CCN2 | 6.10e-09 | 192 | 233 | 11 | 5d5bec238b196f0b3e727fd94f078d6ae524cb01 |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | CFH FBN1 RBMS3 C3 C1QTNF2 SRPX FHL1 SEMA3C LAMA2 LAMA4 PCOLCE2 | 6.10e-09 | 192 | 233 | 11 | cf2765d8bc074f7f9ee864eae632a3b705175842 |
| Computational | Adhesion molecules. | 1.29e-06 | 141 | 133 | 11 | MODULE_122 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | ADAM9 ADAM10 FAT1 GANAB TMEM131L ATRN SEMA3C MBOAT7 CLSTN1 IGF2R AGRN | 8.82e-07 | 161 | 233 | 11 | 3556_DN |
| Drug | hydroxyl radicals | CYP2A13 ZNF143 CHIA MYCBP2 USP11 MAML1 PFAS GCDH USP20 GANAB PLA2G12B USP32 FGB CHRDL1 C3 PLCD1 HSD11B2 USP1 HMGCLL1 GOT2 SGSH DUSP1 AOC2 AOX1 PPEF2 PPAT PPEF1 AQP1 ATP1B4 TRIM9 QPRT PRKCQ USP33 | 2.65e-06 | 1341 | 233 | 33 | CID000000961 |
| Drug | dicyclohexyl phthalate | CYP2A13 ACR SRI ADAM10 STAB1 PLA2G12B BSG PCYT2 C3 HSD11B2 ALDOA NCOA2 POLD1 ASAH2 CAPN2 AOX1 LAMA4 AQP1 ACTR2 IGF2R ARAP3 TIAM1 CCN2 PRKCQ | 5.66e-06 | 836 | 233 | 24 | ctd:C036042 |
| Drug | Letrozole [112809-51-5]; Up 200; 14uM; PC3; HT_HG-U133A | CFH ADAM20 ARID5A HOXA7 NF1 NFATC3 PGP LAMB4 TRMO VPS9D1 PDE4DIP | 6.28e-06 | 197 | 233 | 11 | 4240_UP |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Up 200; 23.6uM; PC3; HT_HG-U133A | FRS3 NF1 NFATC3 SEMA3C KCNAB2 LAMA4 TRMO SEC61A2 CSF1R TIAM1 PDE4DIP | 6.59e-06 | 198 | 233 | 11 | 7293_UP |
| Drug | Biotin [58-85-5]; Up 200; 16.4uM; MCF7; HT_HG-U133A | CLSTN3 FOXN3 ITGB4 ARID5A USP20 FZD9 ELAPOR1 KCNAB2 PPEF1 CLIP4 PDE12 | 6.59e-06 | 198 | 233 | 11 | 3289_UP |
| Drug | Sotalol hydrochloride [959-24-0]; Up 200; 13uM; PC3; HT_HG-U133A | CLSTN3 ITGB4 NF1 RBMS3 FGB ZNF345 LAMA2 RGS12 PDE12 CSF1R PRKCQ | 6.59e-06 | 198 | 233 | 11 | 4079_UP |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | USP20 NRXN3 UGCG CCNA1 DUSP1 LAMA4 TRIM9 PDE4DIP CCN2 TNFAIP3 | 1.50e-05 | 177 | 233 | 10 | 5745_UP |
| Disease | Stage IV Skin Melanoma | 5.35e-10 | 7 | 227 | 5 | C1321872 | |
| Disease | Atypical hemolytic-uremic syndrome | 3.65e-05 | 9 | 227 | 3 | cv:C2931788 | |
| Disease | Hemolytic-uremic syndrome | 3.65e-05 | 9 | 227 | 3 | cv:C0019061 | |
| Disease | complement C3B measurement | 5.89e-05 | 2 | 227 | 2 | EFO_0020275 | |
| Disease | c3d:C3 ratio | 5.89e-05 | 2 | 227 | 2 | EFO_0008543 | |
| Disease | Age related macular degeneration | 7.99e-05 | 30 | 227 | 4 | C0242383 | |
| Disease | late-onset Alzheimers disease | 9.61e-05 | 292 | 227 | 10 | EFO_1001870 | |
| Disease | amyotrophic lateral sclerosis (biomarker_via_orthology) | 1.21e-04 | 13 | 227 | 3 | DOID:332 (biomarker_via_orthology) | |
| Disease | complement C3D fragment measurement | 1.76e-04 | 3 | 227 | 2 | EFO_0020277 | |
| Disease | calnexin measurement | 1.76e-04 | 3 | 227 | 2 | EFO_0801444 | |
| Disease | complement C3 measurement | 1.76e-04 | 3 | 227 | 2 | EFO_0004983 | |
| Disease | connective tissue disease (implicated_via_orthology) | 1.76e-04 | 3 | 227 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | complement factor H-related protein 4A measurement | 1.76e-04 | 3 | 227 | 2 | EFO_0600057 | |
| Disease | histone-lysine N-methyltransferase 2D measurement | 1.76e-04 | 3 | 227 | 2 | EFO_0801683 | |
| Disease | colorectal carcinoma (is_marker_for) | 1.85e-04 | 37 | 227 | 4 | DOID:0080199 (is_marker_for) | |
| Disease | Age-related macular degeneration | 3.37e-04 | 18 | 227 | 3 | cv:C0242383 | |
| Disease | NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial measurement | 3.50e-04 | 4 | 227 | 2 | EFO_0803292 | |
| Disease | 1-oleoyl-GPI (18:1) measurement | 3.50e-04 | 4 | 227 | 2 | EFO_0800265 | |
| Disease | Paraparesis, Spastic | 3.50e-04 | 4 | 227 | 2 | C0037771 | |
| Disease | scavenger receptor class F member 2 measurement | 3.50e-04 | 4 | 227 | 2 | EFO_0020716 | |
| Disease | scoliosis (is_implicated_in) | 3.50e-04 | 4 | 227 | 2 | DOID:0060249 (is_implicated_in) | |
| Disease | kallikrein-5 measurement | 3.50e-04 | 4 | 227 | 2 | EFO_0020515 | |
| Disease | neurexin-3-beta measurement | 3.50e-04 | 4 | 227 | 2 | EFO_0020597 | |
| Disease | hypertension (biomarker_via_orthology) | 3.96e-04 | 227 | 227 | 8 | DOID:10763 (biomarker_via_orthology) | |
| Disease | Malignant neoplasm of salivary gland | 3.97e-04 | 45 | 227 | 4 | C0220636 | |
| Disease | Congenital hernia of foramen of Morgagni | 3.97e-04 | 19 | 227 | 3 | C0265699 | |
| Disease | Congenital hernia of foramen of Bochdalek | 3.97e-04 | 19 | 227 | 3 | C0265700 | |
| Disease | age at onset, smoking initiation | 3.97e-04 | 19 | 227 | 3 | EFO_0004847, EFO_0005670 | |
| Disease | Salivary Gland Neoplasms | 4.69e-04 | 47 | 227 | 4 | C0036095 | |
| Disease | Congenital diaphragmatic hernia | 5.39e-04 | 21 | 227 | 3 | C0235833 | |
| Disease | birth weight, pelvic organ prolapse | 5.51e-04 | 49 | 227 | 4 | EFO_0004344, EFO_0004710 | |
| Disease | hereditary spastic paraplegia 76 (implicated_via_orthology) | 5.80e-04 | 5 | 227 | 2 | DOID:0110821 (implicated_via_orthology) | |
| Disease | syntaxin-1a measurement | 5.80e-04 | 5 | 227 | 2 | EFO_0020759 | |
| Disease | macula measurement | 6.81e-04 | 189 | 227 | 7 | EFO_0008375 | |
| Disease | diastolic blood pressure, alcohol consumption measurement | 7.98e-04 | 54 | 227 | 4 | EFO_0006336, EFO_0007878 | |
| Disease | traumatic brain injury (biomarker_via_orthology) | 8.07e-04 | 24 | 227 | 3 | DOID:0081292 (biomarker_via_orthology) | |
| Disease | phosphatidylinositol measurement | 8.52e-04 | 95 | 227 | 5 | EFO_0010230 | |
| Disease | v-set and transmembrane domain-containing protein 4 measurement | 8.66e-04 | 6 | 227 | 2 | EFO_0803247 | |
| Disease | brain disease (implicated_via_orthology) | 8.66e-04 | 6 | 227 | 2 | DOID:936 (implicated_via_orthology) | |
| Disease | neurodegenerative disease (biomarker_via_orthology) | 8.66e-04 | 6 | 227 | 2 | DOID:1289 (biomarker_via_orthology) | |
| Disease | complement C1s subcomponent measurement | 8.66e-04 | 6 | 227 | 2 | EFO_0008091 | |
| Disease | glucosidase 2 subunit beta measurement | 8.66e-04 | 6 | 227 | 2 | EFO_0801628 | |
| Disease | emphysema imaging measurement | 9.61e-04 | 146 | 227 | 6 | EFO_0007626 | |
| Disease | Liver Cirrhosis, Experimental | SRI SLC25A30 MEOX2 FAT1 FBN1 NECTIN2 UGCG FHL1 ATRN LCN2 CRY1 IGF2R CSF1R SHCBP1 CCN2 | 1.04e-03 | 774 | 227 | 15 | C0023893 |
| Disease | cortical thickness | RELN MYCBP2 ADAM10 STAB1 FZD9 PLEKHG1 FBN1 FBN2 JAG1 KCNK3 FOXC2 NCOA2 SHROOM3 FAT3 LAMA2 ADAM12 ALX1 CNKSR3 CFAP57 | 1.05e-03 | 1113 | 227 | 19 | EFO_0004840 |
| Disease | status epilepticus (biomarker_via_orthology) | 1.07e-03 | 100 | 227 | 5 | DOID:1824 (biomarker_via_orthology) | |
| Disease | pulse pressure measurement | CFH ZNF831 AHDC1 ADCY5 ARID5A HOXA7 PLEKHG1 MELTF FBN1 FBN2 JAG1 KCNK3 MKLN1 FHL1 SHROOM3 ATG7 FAT3 DELEC1 INO80 TBL1XR1 LHFPL2 PCOLCE2 | 1.16e-03 | 1392 | 227 | 22 | EFO_0005763 |
| Disease | atrophic macular degeneration, age-related macular degeneration, wet macular degeneration | 1.19e-03 | 60 | 227 | 4 | EFO_0001365, EFO_0004683, EFO_1001492 | |
| Disease | regulator of G-protein signaling 8 measurement | 1.21e-03 | 7 | 227 | 2 | EFO_0801997 | |
| Disease | electrodermal activity measurement, skin conductance response amplitude | 1.21e-03 | 7 | 227 | 2 | EFO_0006866, EFO_0006868 | |
| Disease | retinal detachment | 1.21e-03 | 7 | 227 | 2 | EFO_0005773 | |
| Disease | glutathione s-transferase p measurement | 1.21e-03 | 7 | 227 | 2 | EFO_0020410 | |
| Disease | complement factor H-related protein 2 measurement | 1.42e-03 | 29 | 227 | 3 | EFO_0600055 | |
| Disease | diastolic blood pressure, unipolar depression | 1.56e-03 | 30 | 227 | 3 | EFO_0003761, EFO_0006336 | |
| Disease | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 measurement | 1.60e-03 | 8 | 227 | 2 | EFO_0801373 | |
| Disease | calcium/calmodulin-dependent protein kinase type 1D measurement | 1.60e-03 | 8 | 227 | 2 | EFO_0008063 | |
| Disease | switch-associated protein 70 measurement | 1.60e-03 | 8 | 227 | 2 | EFO_0802107 | |
| Disease | atypical hemolytic-uremic syndrome (is_implicated_in) | 1.60e-03 | 8 | 227 | 2 | DOID:0080301 (is_implicated_in) | |
| Disease | creatinine measurement | CFH USP11 PSMA6 USP20 NRXN2 NECTIN2 USP32 TMEM131L MYBPHL ASCC3 SHROOM3 LAMA2 INO80 RGS12 FAM135B IGF2R CFAP57 | 1.90e-03 | 995 | 227 | 17 | EFO_0004518 |
| Disease | age-related macular degeneration, COVID-19 | 1.99e-03 | 69 | 227 | 4 | EFO_0001365, MONDO_0100096 | |
| Disease | apolipoprotein B measurement | ZNF229 FZD9 NF1 NECTIN2 ELAPOR1 KCNK3 FGB MYBPHL USP1 RGS12 IGF2R NCAN PCOLCE2 | 2.00e-03 | 663 | 227 | 13 | EFO_0004615 |
| Disease | cellular retinoic acid-binding protein 1 measurement | 2.05e-03 | 9 | 227 | 2 | EFO_0801463 | |
| Disease | tumor necrosis factor ligand superfamily member 14 measurement | 2.05e-03 | 9 | 227 | 2 | EFO_0010613 | |
| Disease | C3 glomerulopathy | 2.05e-03 | 9 | 227 | 2 | C4087273 | |
| Disease | endothelin-converting enzyme 1 measurement | 2.05e-03 | 9 | 227 | 2 | EFO_0008121 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily A member 5 measurement | 2.05e-03 | 9 | 227 | 2 | EFO_0801766 | |
| Disease | 1-palmitoyl-2-oleoyl-GPI (16:0/18:1) measurement | 2.05e-03 | 9 | 227 | 2 | EFO_0800439 | |
| Disease | RNA-binding protein 24 measurement | 2.05e-03 | 9 | 227 | 2 | EFO_0802030 | |
| Disease | Complement deficiency disease | 2.07e-03 | 33 | 227 | 3 | C0272242 | |
| Disease | hematocrit | PFAS GCDH STAB1 PRR12 PLEKHG1 FAT1 RBMS3 JAG1 KCNK3 CHRDL1 EMC10 ZNF345 SHROOM3 ZAN RBMS2 HECTD4 MFSD2A | 2.24e-03 | 1011 | 227 | 17 | EFO_0004348 |
| Disease | refractive error, self reported educational attainment | 2.25e-03 | 34 | 227 | 3 | EFO_0004784, MONDO_0004892 | |
| Disease | retinal detachment, retinal break | 2.45e-03 | 35 | 227 | 3 | EFO_0005773, EFO_0010698 | |
| Disease | Bone Diseases | 2.55e-03 | 10 | 227 | 2 | C0005940 | |
| Disease | DNA-directed RNA polymerases I and III subunit RPAC1 measurement | 2.55e-03 | 10 | 227 | 2 | EFO_0801535 | |
| Disease | Atypical Hemolytic Uremic Syndrome | 2.55e-03 | 10 | 227 | 2 | C2931788 | |
| Disease | Chronic Kidney Diseases | 2.55e-03 | 10 | 227 | 2 | C1561643 | |
| Disease | protein eva-1 homolog C measurement | 2.55e-03 | 10 | 227 | 2 | EFO_0801942 | |
| Disease | OCIA domain-containing protein 1 measurement | 2.55e-03 | 10 | 227 | 2 | EFO_0008252 | |
| Disease | 1-stearoyl-2-oleoyl-GPI (18:0/18:1) measurement | 2.55e-03 | 10 | 227 | 2 | EFO_0800469 | |
| Disease | pneumonia (implicated_via_orthology) | 2.55e-03 | 10 | 227 | 2 | DOID:552 (implicated_via_orthology) | |
| Disease | juvenile idiopathic arthritis | 2.58e-03 | 74 | 227 | 4 | EFO_0002609 | |
| Disease | Acute Myeloid Leukemia, M1 | 2.86e-03 | 125 | 227 | 5 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 2.86e-03 | 125 | 227 | 5 | C1879321 | |
| Disease | response to statin, myopathy | 3.10e-03 | 11 | 227 | 2 | EFO_0004145, GO_0036273 | |
| Disease | hemopexin measurement | 3.10e-03 | 11 | 227 | 2 | EFO_0008149 | |
| Disease | systolic blood pressure, alcohol drinking | 3.17e-03 | 128 | 227 | 5 | EFO_0004329, EFO_0006335 | |
| Disease | Hypermetropia, Myopia | 3.53e-03 | 189 | 227 | 6 | HP_0000540, HP_0000545 | |
| Disease | Charcot-Marie-Tooth disease (is_implicated_in) | 3.70e-03 | 12 | 227 | 2 | DOID:10595 (is_implicated_in) | |
| Disease | oncostatin-M measurement | 3.70e-03 | 12 | 227 | 2 | EFO_0010792 | |
| Disease | tyrosine-protein kinase ZAP-70 measurement | 3.70e-03 | 12 | 227 | 2 | EFO_0020833 | |
| Disease | pulmonary embolism (biomarker_via_orthology) | 3.70e-03 | 12 | 227 | 2 | DOID:9477 (biomarker_via_orthology) | |
| Disease | cognitive function measurement | CELF4 NCAM2 MDGA2 FOXN3 STAB1 CAPN8 PRR12 PLEKHG1 SGCZ NRXN3 GANAB NCOA2 DMXL2 MMS22L DELEC1 FAM135B ARAP3 FAM222A CNKSR3 LHFPL2 MUC2 | 3.70e-03 | 1434 | 227 | 21 | EFO_0008354 |
| Disease | birth weight, parental genotype effect measurement | 3.81e-03 | 192 | 227 | 6 | EFO_0004344, EFO_0005939 | |
| Disease | complement factor H measurement | 3.86e-03 | 41 | 227 | 3 | EFO_0008097 | |
| Disease | age-related macular degeneration, disease progression measurement | 3.86e-03 | 41 | 227 | 3 | EFO_0001365, EFO_0008336 | |
| Disease | virologic response measurement, response to abacavir | 4.13e-03 | 42 | 227 | 3 | EFO_0006905, EFO_0006906 | |
| Disease | Autism Spectrum Disorders | 4.25e-03 | 85 | 227 | 4 | C1510586 | |
| Disease | tumor necrosis factor ligand superfamily member 8 measurement | 4.35e-03 | 13 | 227 | 2 | EFO_0010592 | |
| Disease | retinol dehydrogenase 16 measurement | 4.35e-03 | 13 | 227 | 2 | EFO_0802007 | |
| Disease | Agents acting on the renin-angiotensin system use measurement | 4.60e-03 | 335 | 227 | 8 | EFO_0009931 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YSKASAGKCVQAFGP | 41 | Q15699 | |
| TLPLFKYIGGCQVGS | 181 | Q2TAA5 | |
| PNCLIKGYGGSVDSG | 651 | Q9UKF5 | |
| CGVGLPTSFTVGQYF | 331 | Q5U5X8 | |
| SVSFVGASGCPEAYK | 226 | Q03989 | |
| PSCYGNIKNDNGGSS | 1711 | Q96N23 | |
| AAGEKSYGKPCGGQD | 21 | Q14031 | |
| APKGYLKNTCSSGGG | 131 | P61568 | |
| GQASLLGAQKCYGPE | 341 | Q96FG2 | |
| GFLYCSPVSNKAGPS | 681 | Q8WWN8 | |
| AYDCGEGPDGANTKK | 111 | Q9BQT9 | |
| FGRQAGGPVQAAAYC | 171 | A6NCS6 | |
| KYGPQGGCADHSVFE | 166 | O14672 | |
| PYCKDKGYGGSADSG | 661 | O43506 | |
| AGYPVGKIDTCQGDS | 226 | P10323 | |
| QDLYFGSFCPGGSIK | 491 | Q9H5V8 | |
| ATFPGTVCNKSYDAG | 286 | Q9Y3Q7 | |
| FGKGAQGAPFACFKE | 506 | Q9Y3Q7 | |
| SLACQGKYTPSGQAG | 336 | P04075 | |
| GLYVAAQGACRGPTF | 741 | O00468 | |
| CKVGFAGQASPTYTV | 61 | Q8TC94 | |
| YTGCGINPARSFGSA | 186 | P29972 | |
| AASGKFTCNIPGTYF | 161 | O75973 | |
| GSGFCAVRANGLYPV | 426 | Q9BZP6 | |
| GCTPGSGKDYAGVFS | 626 | P01024 | |
| RVNSAGDPYGNCGKV | 551 | O43184 | |
| GDPYGNCGKVSKSSF | 556 | O43184 | |
| FCDKFGFGGSTDSGP | 686 | O43184 | |
| FFRKGGGACLSNAPD | 396 | Q9BZ11 | |
| FGKGSRNAPFACYEE | 506 | Q8TC27 | |
| AKLNGCYEALAGGST | 186 | A6NHC0 | |
| TYKCFEGFGIDGPAI | 956 | P08603 | |
| GSVGDVPFTAYGSGC | 21 | Q8TDJ6 | |
| FTIQAYDCGKGPDGT | 126 | O94985 | |
| KDCSFAYGSGNSLPA | 996 | Q5TGY3 | |
| VNYSLGDEQGFCGSP | 886 | O95622 | |
| FPFLNKSDSGTYGCT | 286 | Q8N126 | |
| YPCLGAYGTSKAAVA | 226 | P80365 | |
| NDGSVGGVQYFSCSP | 526 | Q8N3C7 | |
| RAGYDGESIGNCPFS | 476 | Q96NY7 | |
| FLKNCSGLEDPTFGY | 226 | Q9UN42 | |
| GEAFTKCGFAGETGP | 21 | Q9NZ32 | |
| GFVKCGYAGSNFPEH | 16 | P61160 | |
| YFNTFGGSPVSCAVG | 306 | Q8IUZ5 | |
| ISYGGVGPATICAKN | 461 | Q06278 | |
| SGKGFSGTFQLCFPY | 401 | Q5SSJ5 | |
| KYFDEGRGSCPFGEN | 406 | Q13434 | |
| SGALEGQPRGYCFVN | 61 | Q96H35 | |
| CKGYGFVDFDSPSAA | 96 | Q15434 | |
| CKGYGFVDFDSPAAA | 101 | Q6XE24 | |
| KSGTGFGESYSLANP | 486 | Q9ULG1 | |
| YLQGLVSFGKAPCGQ | 216 | Q9Y5K2 | |
| YGHAAPGTDAGKAFC | 96 | Q9NPC2 | |
| PGSVYFEKGQDAGLC | 716 | O75106 | |
| AEGLEPLSGKYFSDC | 271 | Q96NR8 | |
| LQYKFDCGSGPGIVS | 3886 | Q14517 | |
| YKADCGQGSPGSGQS | 521 | Q92585 | |
| PSCYGGYGFSILLKS | 51 | Q3LI73 | |
| LGDAKTNTFCGTPDY | 531 | Q04759 | |
| ALPKYGCIENTGTGD | 1876 | Q86XX4 | |
| NLGGEKNGYVTCPFR | 631 | Q8NI17 | |
| RCKPGYDSQGSLDGL | 711 | Q17R60 | |
| YGHAAPGTDSGKVFC | 96 | Q9H427 | |
| YGHAAPSTDGGKVFC | 96 | O14649 | |
| PPYFSCAVDNRGGGK | 26 | Q6ZRQ5 | |
| GSAYLEAGGTKVLCA | 51 | Q5RKV6 | |
| LYGSKGIFTCTPSAG | 661 | Q5VTL7 | |
| KTCKPALGYSFAAGT | 446 | Q9NR71 | |
| YSKGFACSAGPGRVL | 291 | Q96MR6 | |
| TCISGFYGDPTNGGK | 1091 | O75882 | |
| SSGCDYALFKDGIQP | 111 | A6NMX2 | |
| LDIVCGKGTDFNYGP | 331 | Q2LD37 | |
| FPCKPGTYADKQGSS | 276 | Q6UXG2 | |
| SVCTGYGNLSDQPYG | 916 | Q15751 | |
| AAVLGSGGKSNDPCY | 2816 | Q15751 | |
| SGGKSNDPCYLQSPG | 2821 | Q15751 | |
| NASSGKFVCGVPGIY | 181 | Q9BXJ5 | |
| VATNTDGKNYCGLPG | 306 | P02675 | |
| REYADSFGKCPGGRN | 171 | Q99447 | |
| APSYKGTVCGLCGNF | 981 | Q02817 | |
| KNEDQFGNGPFGLCY | 1366 | Q02817 | |
| KSACGEPAYTNYVGG | 541 | Q6L8Q7 | |
| GPGASLEVFGTAYCT | 91 | A6NDG6 | |
| CPKCGSTGESGNANY | 41 | Q8IXT1 | |
| GDGTGACYLLPVFDT | 66 | Q8N8A8 | |
| VCNDPGTTYIFGKGG | 1131 | Q9P2S2 | |
| SGNQCNDPGATYIFG | 1081 | Q9Y4C0 | |
| PGYGSTLFDVECKEG | 1951 | Q9HD67 | |
| LCGPYAESFGEIASG | 81 | Q6ZUX7 | |
| CIAAGFGAYPVAAKA | 256 | Q96N66 | |
| GSTAYLLCKAFGAPV | 441 | P32004 | |
| GSTSCIPFFYGGDKK | 601 | A0A1B0GV03 | |
| APSGNYVACGGLDNI | 106 | Q9HAV0 | |
| GFYGEPTKGTSEDCQ | 791 | P24043 | |
| AAYGQPCAQGLEAGA | 311 | Q99958 | |
| DCPGLNYAALVSGAG | 26 | Q15274 | |
| GAACAPGDYGRQALS | 141 | P50222 | |
| NGCGSYFLGLKVPES | 86 | Q9BX93 | |
| DQYCGGLLDRPSGSF | 151 | Q9UKZ9 | |
| LCVKLASGGDPTYAF | 3621 | Q9Y4D8 | |
| GGGCSGFQYKFSLDT | 76 | Q86U28 | |
| VCAYGAQGEGPYSSL | 1196 | P16144 | |
| GPGSCKLFGFIFYTN | 86 | P46093 | |
| LACGIVSGKYDSGIP | 246 | Q13303 | |
| FVSYVTLPGGSCFGN | 66 | Q8N485 | |
| GRYYCKAENGLGSPA | 106 | Q7Z553 | |
| DFGTYTCVASLKGGG | 411 | Q7Z553 | |
| GTGCGTLNDGKSLYF | 1471 | P78509 | |
| AAPKDAGIYGCLASN | 671 | Q96RW7 | |
| GRFQDNGACGYVLKP | 591 | P51178 | |
| YNATVFAYGPTGCGK | 96 | Q2TAC6 | |
| KLCYALGGAPYQVTG | 46 | Q8NA29 | |
| GCQPGEFTLGNIKSY | 106 | P80188 | |
| IGTGSFFPKGEDFYC | 136 | Q13642 | |
| GGCTNPYGKSKFFIE | 151 | Q14376 | |
| GGSGTCENPEKFQYV | 191 | O00144 | |
| GLPCDYTANSKGGVT | 256 | P07199 | |
| INGSGTLLCAASGYP | 411 | P07333 | |
| GFYKCVASNPGGQDS | 1816 | Q6WRI0 | |
| YGGLASITAECGTFP | 11 | Q5SVS4 | |
| GSSLFANIPGYKLGC | 536 | O95352 | |
| PFSIGKRYCFGEGLA | 431 | Q16696 | |
| PGQSFDNKGYFCGEE | 331 | Q9BU40 | |
| SSLGGPFGCLNNARY | 281 | Q92947 | |
| APSGNYVACGGLDNI | 106 | P62873 | |
| LKGGYEAFSASCPEL | 121 | P28562 | |
| LSAGDPCKGGYVSFN | 306 | Q5THR3 | |
| GVCYNGGKDFAVSLA | 46 | Q9P2X7 | |
| NTSEYKILCPGGEGF | 1581 | P35555 | |
| TAKDGAPCIFGGTVY | 96 | P29279 | |
| GYTVSSFSNGCPGEG | 141 | O43559 | |
| GLSQCYGGSGFSKAL | 21 | O00409 | |
| CYSGSENAFPPAGKK | 106 | P78396 | |
| GGFMGYSAENIPGCS | 511 | Q16526 | |
| VFGSFLCNCTPGYVG | 4116 | Q8TDW7 | |
| GLSNCAGILGYSDPF | 206 | P57058 | |
| AGILGYSDPFSTQCG | 211 | P57058 | |
| PGQYRCNGTSSKGSD | 296 | P35613 | |
| AYSAPSCGNKLVDAG | 411 | Q13443 | |
| GVQGGTLCFSKLDYA | 336 | Q16739 | |
| NCKPGYATAEGNSSG | 116 | Q92496 | |
| NSCKDPYGGSEGTFS | 131 | Q8N4S9 | |
| FDGGIYTCKAVNPLG | 326 | A2RUH7 | |
| PGQSYGLEDGSCSYK | 461 | P14866 | |
| PTNYGFCFKPNKAGG | 301 | Q14449 | |
| GASTAIFVCNYGPAG | 161 | Q6UWM5 | |
| ECSTGFYGNPRISGA | 951 | A4D0S4 | |
| GLEAGGYVSSFVPAC | 121 | Q5UCC4 | |
| VFGAGYCKPTSSEGS | 211 | Q49AJ0 | |
| VGNCYLKFGPRGDGS | 1576 | P35556 | |
| AKINGCYEALSGGAT | 186 | P17655 | |
| SCSPLSYAGLGSDGK | 131 | A6NEL3 | |
| QYPGRGSAEGCDFSI | 46 | Q9BRL7 | |
| AYTCSASPGGEGQSL | 131 | Q96H72 | |
| YGFTGAQVGKLPCLE | 701 | P28340 | |
| CYAGPSNVGAGSLDI | 736 | Q5FWE3 | |
| YSICQDTALGGPGFQ | 256 | P35462 | |
| GLGADAYGNLPCASY | 71 | P31268 | |
| KANTIRGGGCYFGPD | 456 | O14830 | |
| GGSPISAQYANFTGC | 1356 | Q16363 | |
| EYQSRVTAGGPCSFG | 81 | P78504 | |
| RGGGCYFGPDVTSKI | 376 | O14829 | |
| SGDNGYTTCFIPGNL | 376 | Q9Y5H4 | |
| VDSAVSGLGGCPYAK | 301 | Q8TB92 | |
| CPYAKGASGNVATED | 311 | Q8TB92 | |
| YSKGYPCGGNKTASS | 2076 | P11717 | |
| TQGSFSGRCPLYGVA | 31 | Q7Z7N9 | |
| KGDGFQCSGVPAPTY | 11 | Q9NQ03 | |
| YIPTAAAFGGLCIGA | 416 | Q9H9S3 | |
| GSGAFSPVCTYLNRG | 131 | Q99985 | |
| LKAVSDYFGGSCVPG | 161 | P08582 | |
| CGVFYPSSLAFTKNG | 151 | Q8IUX1 | |
| LDTYGPSDKGRGKNC | 936 | A2VDJ0 | |
| NGTGPCTYNKSGSRE | 496 | Q86VH5 | |
| KVHYLFGGNPGKSCS | 596 | Q9UL63 | |
| AYEAGLIGKNACGSG | 176 | P49821 | |
| LIGKNACGSGYDFDV | 181 | P49821 | |
| DGCGYLPSFESQGQL | 241 | Q5SWL8 | |
| LSFCGADVGGFFKNP | 641 | Q14697 | |
| NGFVCLCLPSYGGSF | 1066 | O14594 | |
| GLYDFGPVGCALKNN | 146 | P41250 | |
| GSGGKYAEPVFECNV | 106 | Q53H47 | |
| YPLDKGAEGCSAGAQ | 536 | Q13796 | |
| GQDSGFGLVKDPCYL | 1256 | Q8TF72 | |
| DGQPGAFTCYLDAGL | 136 | P46777 | |
| YSYGLCPGNGTTKEE | 221 | Q8NBI5 | |
| KGASCSAQGFDYGLG | 2696 | O75592 | |
| GKLYNTCAVFGPDGT | 91 | Q9NQR4 | |
| GKLYLSPAGVGSTCQ | 276 | Q96LD1 | |
| GAKGAGIEIYPGSQC | 486 | Q8NEM2 | |
| KCQSLGGPAAAYATG | 416 | Q9ULL5 | |
| APQGGYYKTALGTRC | 71 | P78539 | |
| PANGGFKCVDGAYFN | 126 | P78539 | |
| AAGLSPYADKGKCGL | 6 | Q8N6T7 | |
| GRLAANGGGYCVSKF | 166 | Q92781 | |
| NGGGYCVSKFGLEAF | 171 | Q92781 | |
| SQPQYGTFCEKFGNG | 186 | P51688 | |
| SPDGRYLASGSFDKC | 451 | Q9BZK7 | |
| YLPIGGLAEFCKASA | 96 | P00505 | |
| GPDGNSKGCAFVKYS | 186 | Q9BZC1 | |
| FCELSTPGGVENSYG | 1041 | Q8N3C0 | |
| GSFVYGGSSKCKQPL | 361 | G9CGD6 | |
| GSFVYGGSSKCKQPL | 361 | Q6P9H4 | |
| DSKDCFGLYGEPSEG | 581 | Q15596 | |
| FGIGCAEVNKPGVYT | 421 | P57727 | |
| PAGYYCGFKATAAGV | 156 | P60900 | |
| EPVGYLESCFSAKNG | 31 | Q9BU70 | |
| SYGPDGNGFSLGCSK | 251 | Q5W0Z9 | |
| EPGCGRAFASATNYK | 361 | P52747 | |
| GYGFTLSGQAPCVLS | 31 | O14924 | |
| NGGPGSKFAGYCRNL | 246 | Q13009 | |
| GGPYVCRATNKAGED | 276 | O15394 | |
| GCVYFGTPENKGFCT | 611 | P21580 | |
| GLPKCSGLTQNSGDY | 901 | A0A1B0GUW6 | |
| AAPKDDGFLNGSCSG | 556 | Q03431 | |
| YIPTAAAFGGLCIGA | 416 | P61619 | |
| AGCASGTEKFGYLPA | 276 | Q6ZMY3 | |
| GTKCDQPCATGFYGE | 311 | Q96GP6 | |
| SNGASDYGNKFGEPV | 386 | O15067 | |
| GARPYECGQCGKSFS | 431 | Q3SY52 | |
| VCGAAKLYLGSSVFG | 421 | Q9NYB5 | |
| ESATPAALAYAGKCG | 326 | Q06203 | |
| SVSPCGKFLAAGNNY | 31 | Q86W42 | |
| LFYGVGCDIPSSGNT | 626 | P21359 | |
| GLGSQYPLKKDSCGD | 376 | Q12968 | |
| RSYGGIIPNTSFCAG | 241 | Q86WS5 | |
| FSNPCYGKGNCSDGI | 736 | Q9NY15 | |
| LDYKGGLFCSALPGA | 826 | O15040 | |
| VPAKPGACGDSYAAQ | 496 | Q9Y2K6 | |
| ESYDACKGDSGGPLV | 241 | Q6UWB4 | |
| AECGKGFSYSSGLLI | 631 | Q9UJW7 | |
| YGGFASAPTTPCQKS | 81 | Q9C026 | |
| FGCNEYGKAFSPTSR | 566 | Q9BRH9 | |
| GFALGIKCGASYAQV | 476 | Q9NNW7 | |
| LGGSSFFEKDGAPFC | 261 | O43294 | |
| AFFPACYSGDGRLKS | 416 | Q9H598 | |
| GFCYSPEGGTKALFG | 441 | Q9ULL1 | |
| PYECIDCGKAFGSGS | 201 | Q14585 | |
| AKGATGYPYCAAAQE | 501 | Q9Y2B5 | |
| HKTFFPSRGQYGCGE | 1586 | Q5JPB2 | |
| YVQGGDQDSSTFPGC | 116 | P51784 | |
| RCLTQSGIAGGYKPF | 56 | P30626 | |
| SGIAGGYKPFNLETC | 61 | P30626 | |
| GSGFLYSATPGADVC | 476 | Q8NFA0 | |
| EFDCYGGGLSKINTP | 541 | O94782 | |
| SIVKAGSCGEAYAPQ | 526 | Q8TEY7 | |
| KNGQYGCHPYAGTAT | 1141 | Q9Y493 | |
| PGSGEEKAFQFYNSC | 141 | P23276 | |
| EKYGKDSCQGDSGGP | 186 | Q92876 | |
| SDGTGAFYSPGLQAK | 1421 | Q5VU43 | |
| GNYTCEFATFPKGSV | 136 | Q92692 |